<SEC-DOCUMENT>0000950170-24-033921.txt : 20240320
<SEC-HEADER>0000950170-24-033921.hdr.sgml : 20240320
<ACCEPTANCE-DATETIME>20240319213211
ACCESSION NUMBER:		0000950170-24-033921
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20240319
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240320
DATE AS OF CHANGE:		20240319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GERON CORP
		CENTRAL INDEX KEY:			0000886744
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				752287752
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20859
		FILM NUMBER:		24766141

	BUSINESS ADDRESS:	
		STREET 1:		919 EAST HILLSDALE BOULEVARD
		STREET 2:		SUITE 250
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6504737700

	MAIL ADDRESS:	
		STREET 1:		919 EAST HILLSDALE BOULEVARD
		STREET 2:		SUITE 250
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GERON CORPORATION
		DATE OF NAME CHANGE:	19960521
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gern-20240319.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-03-19T18:52:06.2294+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:gern="http://www.geron.com/20240319" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_add42bc0-0d89-4bd4-ada7-3913936871af" name="dei:AmendmentFlag" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_a5df678d-2a23-4a70-ae9d-8fcf8e85d4dc" name="dei:EntityCentralIndexKey" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe">0000886744</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="gern-20240319.xsd"/></ix:references><ix:resources><xbrli:context id="C_fd658c12-c345-4597-b50d-ad46331f0ffe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-19</xbrli:startDate><xbrli:endDate>2024-03-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">___________</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b66c2bf3-46c0-4061-a2c4-e4a19928b8e4" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PURSUANT TO SECTION 13 OR 15(d) OF THE</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES EXCHANGE ACT OF 1934</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6d1ddc66-9812-45f2-b332-b00054f6ce70" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 19, 2024</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4ce76943-8eb2-40da-aac8-da7b38be58a2" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">GERON CORPORATION</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:97.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:33.333%;"/>
    <td style="width:33.333%;"/>
    <td style="width:33.333%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_109fb3f7-aff6-4e7c-a44a-206479e4e44e" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7da3a392-7fa6-4b5a-83ef-a5240cfe863e" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">000-20859</span></ix:nonNumeric></span></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6d2ff604-a835-4b72-995c-373d6274e622" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">75-2287752</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(State or other jurisdiction of incorporation)</span></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(IRS Employer Identification No.)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_76f1a2b9-4a66-4549-a925-037685cb200a" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">919 E. HILLSDALE BLVD</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">., </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_922a7db1-52bc-4c06-9a78-6ba3e10931ab" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SUITE 250</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b6a0b199-c016-46a1-b22f-01bc4169235f" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FOSTER CITY</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ddce41ab-a1e2-4e05-b418-2303407a12c8" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CA</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">LIFORNIA </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4147050f-c452-48a7-bb44-080cf1b2182e" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">94404</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (Address of principal executive offices, including zip code)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1071b0fc-0926-4b97-9770-a12db4e63b77" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">650</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e5402aa5-0a18-46db-ab9d-d1120e3bbbed" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">473-7700</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Registrant&#8217;s telephone number, including area code)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">N/A</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Former name or former address, if changed since last report)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_1fe41f89-4ac8-4533-9120-638c5f55563e" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:WrittenCommunications" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_39e4bbfb-c130-4494-a3ed-7925a47e3b79" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:SolicitingMaterial" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_430d6f02-adf2-445b-8fca-ef3f03c9275d" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_ea547a96-6e73-41e3-8049-4fe2dc64de40" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:33.34%;"/>
    <td style="width:22.22%;"/>
    <td style="width:44.44%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title of each class</span></p></td>
    <td style="border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid #000000;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Trading Symbol(s)</span></p></td>
    <td style="border-top:0.5pt solid #000000;border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid #000000;padding-right:0.075in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="border-right:0.5pt solid #000000;border-left:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_f7c32337-52b1-455c-90cb-d13597beeb97" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common Stock, $0.001 par value</span></ix:nonNumeric></span></p></td>
    <td style="border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_039b3c9d-d9ad-4548-a5f9-5283c0dda4e4" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">GERN</span></ix:nonNumeric></span></p></td>
    <td style="border-right:0.5pt solid #000000;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid #000000;padding-right:0.075in;"><p style="text-indent:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:nonNumeric id="F_84400f07-cee6-46da-bd29-0d4d6ef86be7" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company  </span><span style="font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_fe33a804-9aa1-41a3-937e-23fa499276ff" contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="eolpage2"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1</span></p></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 1.01 Entry into a Material Definitive Agreement.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On March 19, 2024, Geron Corporation (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Cowen and Company, LLC and Stifel, Nicolaus &amp; Company, Incorporated, as representatives of the several underwriters named therein (collectively, the &#8220;Underwriters&#8221;), relating to the issuance and sale (the &#8220;Offering&#8221;) of 41,999,998 shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), and pre-funded warrants to purchase 8,002,668 shares of Common Stock (the &#8220;Pre-Funded Warrants&#8221;). All of the shares of Common Stock and Pre-Funded Warrants in the Offering are being sold by the Company. The offering price of each share of Common Stock is $3.00 and the offering price of each Pre-Funded Warrant is $2.999. The gross proceeds to the Company from the Offering, before deducting underwriting discounts and estimated offering expenses, is expected to be approximately $150.0 million. The Offering is expected to close on March 21, 2024, subject to satisfaction of customary closing conditions.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Each Pre-Funded Warrant will have an initial exercise price per share of $0.001, subject to certain adjustments. The Pre-Funded Warrants will be exercisable immediately and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. A holder (together with its affiliates and other attribution parties) may not exercise any portion of a Pre-Funded Warrant to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 9.99% of the Company&#8217;s outstanding Common Stock immediately after exercise, which percentage may be changed at the holder&#8217;s election to a lower or higher percentage not in excess of 19.99% (if exceeding such percentage would result in a change of control under Nasdaq Listing Rule 5635(b) or any successor rule) upon 61 days&#8217; notice to the Company subject to the terms of the Pre-Funded Warrants.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Offering is being made pursuant to the Company&#8217;s automatically effective shelf registration statement on Form S-3 (Registration Statement No. 333-269111), which was filed with the Securities and Exchange Commission on January 4, 2023, and a prospectus supplement thereunder.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters, including for liabilities arising under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for the purposes of such agreement and as of specific dates, and were solely for the benefit of the parties to such agreement.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The foregoing descriptions of the terms of the Underwriting Agreement and Pre-Funded Warrants are each qualified in their entirety by reference to the Underwriting Agreement and form of Pre-Funded Warrant, respectively, which are attached as Exhibit 1.1 and Exhibit 4.1 hereto, respectively, and incorporated by reference herein.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A copy of the legal opinion of Cooley LLP relating to the validity of the issuance and sale of the securities in the Offering is attached as Exhibit 5.1 hereto.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) Exhibits:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</span></p></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:1in;"></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.071%;"/>
    <td style="width:1.01%;"/>
    <td style="width:89.919%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="gern-ex1_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">1.1</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="gern-ex1_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:10pt;min-width:fit-content;">Underwriting Agreement, dated March 19, 2024, by and among Geron Corporation and Cowen and Company, LLC</span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;"> </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;font-size:10pt;min-width:fit-content;">and Stifel, Nicolaus &amp; Company, Incorporated, as representatives of the underwriters named therein</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="gern-ex4_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">4.1</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="gern-ex4_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="gern-ex5_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">5.1</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="gern-ex5_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Cooley LLP</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="gern-ex5_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Cooley LLP (included in Exhibit 5.</span></a><span style="color:#0000ee;white-space:pre-wrap;min-width:fit-content;">1)</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3</span></p></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURE</span></p>
  <p style="margin-left:4.173%;text-indent:-7.477%;padding-left:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:5%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:33.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.121%;"/>
    <td style="width:24.485%;"/>
    <td style="width:9.002%;"/>
    <td style="width:6.301%;"/>
    <td style="width:54.091%;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">GERON CORPORATION</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">March 19, 2024</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">/s/ Scott A. Samuels</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Scott A. Samuels</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</span></p></td>
    <td style="text-indent:252pt;vertical-align:top;"><p style="text-indent:-252pt;padding-left:252pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Executive Vice President,</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="text-indent:252pt;vertical-align:top;"><p style="text-indent:-252pt;padding-left:252pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Legal Officer and</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="text-indent:252pt;vertical-align:top;"><p style="text-indent:-252pt;padding-left:252pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Corporate Secretary</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4</span></p></div>
  <hr style="page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>gern-ex1_1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<html>
 <head>
  <title>EX-1.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 1.1</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Geron Corporation</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">(a Delaware corporation)</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">41,999,998 shares of Common Stock</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Pre-Funded Warrants to Purchase up to 8,002,668 shares of Common Stock</font></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;border-bottom:0.75pt solid;margin-right:38.667%;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Underwriting Agreement</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">March 19, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Cowen and Company, LLC</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Stifel, Nicolaus &amp; Company, Incorporated</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">As representatives (the &#34;Representatives&#34;) of the several Underwriters</font></p>
  <p style="margin-left:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">named in Schedule A hereto,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">c/o Cowen and Company, LLC</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">599 Lexington Avenue</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">New York, New York 10022</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">c/o Stifel, Nicolaus &amp; Company, Incorporated</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">787 Seventh Avenue</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">New York, New York 10019</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Ladies and Gentlemen:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Geron Corporation, a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), confirms its agreement with Cowen and Company, LLC (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">TD Cowen</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> Stifel, Nicolaus &amp; Company, Incorporated (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Stifel</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) and each of the other Underwriters named in Schedule A hereto (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Underwriters,</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom TD Cowen and Stifel are acting as representatives (in such capacity, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Representatives</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), with respect to the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of shares of common stock, par value $0.001 per share, of the Company (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) and pre-funded warrants to purchase shares of Common Stock at an exercise price equal to $0.001 per share (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Pre-Funded Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), set forth in Schedule A hereto The aforesaid 41,999,998 shares of Common Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Common Stock Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) and the Pre-Funded Warrants to purchase 8,002,668 shares of Common Stock to be purchased by the Underwriters are herein called, collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.&#x201d; The shares of Common Stock issuable upon exercise of the Pre-Funded Warrants are hereinafter referred to as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company understands that the Underwriters propose to make an offering of the Securities to purchasers as soon as the Representatives deem advisable after this Agreement has been executed and delivered.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company has prepared and filed with the Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) an automatic shelf registration statement on Form S-3 (File No. 333-269111), including a base prospectus (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Base Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), covering the offering and sale of certain</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">securities, including the Securities and the Warrant Shares, under the Securities Act of 1933, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">1933 Act</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), and the rules and regulations promulgated thereunder (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">1933 Act Regulations</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), which automatic shelf registration became effective under Rule 462(e) under the 1933 Act Regulations (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Rule 462(e)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;). Such registration statement, as of any time, means such registration statement as amended by any post-effective amendments thereto to such time, including the exhibits and any schedules thereto at such time, the documents incorporated or deemed to be incorporated by reference therein at such time pursuant to Item 12 of Form S-3 under the 1933 Act and the documents otherwise deemed to be a part thereof as of such time pursuant to Rule 430B under the 1933 Act Regulations (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Rule 430B</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), is referred to herein as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">;&#x201d; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;"> however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; without reference to a time means such registration statement as amended by any post-effective amendments thereto as of the time of the first contract of sale for the Securities, which time shall be considered the &#x201c;new effective date&#x201d; of such registration statement with respect to the Securities within the meaning of paragraph (f)(2) of Rule 430B, including the exhibits and schedules thereto as of such time, the documents incorporated or deemed incorporated by reference therein at such time pursuant to Item 12 of Form S-3 under the 1933 Act and the documents otherwise deemed to be a part thereof as of such time pursuant to Rule 430B.  Promptly after execution and delivery of this Agreement, the Company will prepare and file a final prospectus relating to the Securities in accordance with the provisions of Rule 424(b) under the 1933 Act Regulations (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Rule 424(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;).  The final prospectus, in the form first furnished or made available to the Underwriters for use in connection with the offering of the Securities, including the documents incorporated or deemed to be incorporated by reference therein pursuant to Item 12 of Form S-3 under the 1933 Act, are collectively referred to herein as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.&#x201d;  For purposes of this Agreement, all references to the Registration Statement, the Base Prospectus, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval system (or any successor system)(&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">EDGAR</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">As used in this Agreement:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Applicable Time</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; means 7:15 A.M., New York City time, on March 19, 2024 or such other time as agreed by the Company and the Representatives.</font></p>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:4.533%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">General Disclosure Package</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; means any Issuer General Use Free Writing Prospectuses issued at or prior to the Applicable Time, the Base Prospectus, as amended or supplemented (including any documents incorporated therein by reference) immediately prior to the Applicable Time and the information included on Schedule B(a) hereto, all considered together.</font></div></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:4.533%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Issuer Free Writing Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; means any &#x201c;issuer free writing prospectus,&#x201d; as defined in Rule 433 of the 1933 Act Regulations (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Rule 433</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), including without limitation any &#x201c;free writing prospectus&#x201d; (as defined in Rule 405 of the 1933 Act Regulations (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Rule 405</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;)) relating to the Securities that is (i) required to be filed with the Commission by the Company, (ii) a &#x201c;road show that is a written communication&#x201d; within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission, or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description of the Securities or of the offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#x2019;s records pursuant to Rule 433(g).</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:4.533%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Issuer General Use Free Writing Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; means any Issuer Free Writing Prospectus that is intended for general distribution to prospective investors (other than a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">bona fide</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> electronic road show,&#x201d; as defined in Rule 433), as evidenced by its being specified in Schedule B(b) hereto.</font></div></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:4.533%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Issuer Limited Use Free Writing Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">All references in this Agreement to financial statements and schedules and other information which is &#x201c;contained,&#x201d; &#x201c;included&#x201d; or &#x201c;stated&#x201d; (or other references of like import) in the Registration Statement, the Base Prospectus or the Prospectus shall be deemed to include all such financial statements and schedules and other information incorporated or deemed incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus, as the case may be, prior to the execution and delivery of this Agreement; and all references in this Agreement to amendments or supplements to the Registration Statement, the Base Prospectus or the Prospectus shall be deemed to include the filing of any document under the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">1934 Act</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), and the rules and regulations promulgated thereunder (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">1934 Act Regulations</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), incorporated or deemed to be incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus, as the case may be, at or after the execution and delivery of this Agreement.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Representations and Warranties.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Representations and Warranties by the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company represents and warrants to each Underwriter as of the date hereof, the Applicable Time and the Closing Time (as defined below) (except to the extent expressly made as of an earlier date, in which case as of such earlier date), and agrees with each Underwriter, as follows:</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Registration Statement and Prospectuses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company meets the requirements for use of Form S-3 under the 1933 Act. The Registration Statement is an &#x201c;automatic shelf registration statement&#x201d; (as defined in Rule 405) and the Securities have been and remain eligible for registration by the Company on such automatic shelf registration statement.</font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Each of the Registration Statement and any post-effective amendment thereto has become effective under the 1933 Act.  No stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued under the 1933 Act, no order preventing or suspending the use of the Base Prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending or, to the Company&#x2019;s knowledge, contemplated.  The Company has complied with each request from the Commission for preservation of documentation or additional information.</font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Each of the Registration Statement and any post-effective amendment thereto, at the time of its effectiveness, each deemed effective date with respect to the Underwriters pursuant to Rule 430B(f)(2) under the 1933 Act Regulations, the Applicable Time and the Closing Time complied and will comply in all material respects with the requirements of the 1933 Act and the 1933 Act Regulations.  Each preliminary prospectus, the Prospectus and any amendment or supplement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">thereto, at the time each was filed with the Commission, and, in each case, at the Applicable Time and the Closing Time complied and will comply in all material respects with the requirements of the 1933 Act Regulations and the Prospectus delivered to the Underwriters for use in connection with this offering was identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">  </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The documents incorporated or deemed to be incorporated by reference in the Registration Statement and the Prospectus, when they became effective or at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with the requirements of the 1934 Act and the 1934 Act Regulations.</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Accurate Disclosure</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Registration Statement, when it became or becomes effective, and the Prospectus, and any amendment or supplement thereto, on the date of such Prospectus or amendment or supplement, conformed and will conform in all material respects with the requirements of the 1933 Act.  Neither the Registration Statement nor any amendment thereto, at its effective time, on the date hereof, at the Closing Time, contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.  At the Applicable Time, neither (A) the General Disclosure Package nor (B) any individual Issuer Limited Use Free Writing Prospectus, when considered together with the General Disclosure Package, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.  Neither the Prospectus nor any amendment or supplement thereto, as of its issue date, at the time of any filing with the Commission pursuant to Rule 424(b), at the Closing Time, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.  The documents incorporated or deemed to be incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, at the time the Registration Statement became effective or when such documents incorporated by reference were filed with the Commission, as the case may be, when read together with the other information in the Registration Statement, the General Disclosure Package or the Prospectus, as the case may be, did not and will not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the case of the General Disclosure Package or the Prospectus in light of the circumstances under which they were made, not misleading.</font></div></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement (or any amendment thereto), the General Disclosure Package or the Prospectus (or any amendment or supplement thereto) made in reliance upon and in conformity with written information furnished to the Company by any Underwriter through the Representatives expressly for use therein.  For purposes of this Agreement, the</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">only information so furnished shall be the information contained in the sixth, seventh and eighth paragraphs under the caption &#34;Underwriting&#34; in the Prospectus (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Underwriter Information</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Issuer Free Writing Prospectuses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Each Issuer Free Writing Prospectus, as of its issue date and as of each Applicable Time, did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including any document incorporated by reference therein, and any preliminary or other prospectus deemed to be a part thereof that has not been superseded or modified. The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company by any Underwriter through the Representatives expressly for use therein. Any offer that is a written communication relating to the Securities made prior to the initial filing of the Registration Statement by the Company or any person acting on its behalf (within the meaning, for this paragraph only, of Rule 163(c) of the 1933 Act Regulations) has been filed with the Commission in accordance with the exemption provided by Rule 163 under the 1933 Act Regulations (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Rule 163</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) and otherwise complied with the requirements of Rule 163, including without limitation the legending requirement, to qualify such offer for the exemption from Section 5(c) of the 1933 Act provided by Rule 163.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Well-Known Seasoned Issuer</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  (A) At the original effectiveness of the Registration Statement, (B) at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the 1933 Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section 13 or 15(d) of the 1934 Act or form of prospectus), (C) at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the 1933 Act) made any offer relating to the Securities in reliance on the exemption of Rule 163 under the 1933 Act, and (D) as of the Applicable Time, the Company was and is a &#x201c;well-known seasoned issuer&#x201d; (as defined in Rule 405).  </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Company Not Ineligible Issuer</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter that the Company or another offering participant made a </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">bona fide</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> offer (within the meaning of Rule 164(h)(2) of the 1933 Act Regulations) of the Securities and at the date hereof, the Company was not and is not an &#x201c;ineligible issuer,&#x201d; as defined in Rule 405, without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Independent Accountants</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Ernst &amp; Young LLP, the accountants who certified the financial statements incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, are independent public accountants as required by the 1933 Act, the 1933 Act Regulations, the 1934 Act, the 1934 Act Regulations and the Public Company Accounting Oversight Board.  To the Company&#x2019;s knowledge, Ernst &amp; Young LLP is not in violation of </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">the auditor independence requirements of the Sarbanes-Oxley Act of 2002 with respect to the Company.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(vii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Financial Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The financial statements incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, together with the related notes, present fairly, in all material respects, the financial position of the Company at the dates indicated and the results of operations, stockholders&#x2019; equity and cash flows of the Company for the periods specified (subject, in the case of unaudited statements, to normal year-end audit adjustments); said financial statements have been prepared in compliance with the requirements of the 1934 Act, as applicable, and in conformity with U.S. generally accepted accounting principles (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">GAAP</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) applied on a consistent basis (except for such adjustments to accounting standards and practices as are noted therein and except in the case of unaudited financial statements to the extent they may exclude footnotes or may be condensed or summary statements) during the periods involved.  The selected financial data and the summary financial information, if any, included in the Registration Statement, the General Disclosure Package and the Prospectus present fairly, in all material respects, the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included therein and the books and records of the Company.  Except as included therein, no historical or pro forma financial statements or supporting schedules are required to be included or incorporated by reference in the Registration Statement, the General Disclosure Package or the Prospectus under the 1933 Act or the 1933 Act Regulations; and the Company does not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations), not described in the Registration Statement (including the exhibits thereto and the documents incorporated by reference therein), the General Disclosure Package and the Prospectus which are required to be described in the Registration Statement, General Disclosure Package or the Prospectus (including exhibits thereto and the documents incorporated by reference therein). The interactive data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly presents the information called for in all material respects and has been prepared in accordance with the Commission's rules and guidelines applicable thereto.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(viii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">No Material Adverse Change in Business</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Neither the Company nor any of its subsidiaries has, since the date of the latest audited financial statements included or incorporated by reference in the General Disclosure Package, (i) sustained any material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree or (ii) entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to the Company and its subsidiaries taken as a whole, in each case otherwise than as set forth or contemplated in the General Disclosure Package; and, since the respective dates as of which information is given in the Registration Statement and the General Disclosure Package, there has not been (x) any change in the capital </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">stock (other than as a result of (i) the exercise, if any, of stock options or the award, if any, of stock options or restricted stock in the ordinary course of business pursuant to the Company&#x2019;s equity plans that are described in the General Disclosure Package and the Prospectus or (ii) the issuance, if any, of stock upon conversion of Company securities as described in the General Disclosure Package and the Prospectus) or long-term debt of the Company or any of its subsidiaries or (y) any Material Adverse Effect (as defined below); as used in this Agreement, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Material Adverse Effect</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; shall mean any material adverse change or effect, or any development involving a prospective material adverse change or effect, in or affecting (i) the business, properties, general affairs, management, financial position, stockholders' equity or results of operations of the Company and its subsidiaries, taken as a whole, except as set forth or contemplated in the General Disclosure Package, or (ii) the ability of the Company to perform its obligations under this Agreement, including the issuance and sale of the Securities, or to consummate the transactions contemplated in the General Disclosure Package and the Prospectus;</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(ix)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Good Standing of the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company has been duly organized and is validly existing as a corporation in good standing under the laws of the State of Delaware and has corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the General Disclosure Package and the Prospectus (including the documents incorporated by reference therein); and the Company is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to be so qualified or in good standing would not result in a Material Adverse Effect.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(x)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Good Standing of Subsidiaries</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company has no significant subsidiaries (as such term is defined in Rule 1-02(w) of Regulation S-X promulgated by the Commission).</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Capitalization</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The issued and outstanding shares of capital stock of the Company have been validly issued, are fully paid and non-assessable and, other than as disclosed in or contemplated by the Registration Statement, the General Disclosure Package and the Prospectus, are not subject to any preemptive rights, rights of first refusal or similar rights.  The Company has an authorized, issued and outstanding capitalization as set forth in the Registration Statement and the Prospectus under the heading &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Description of Capital Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; as of the dates referred to therein (other than the grant of additional options or other equity awards under the Company&#x2019;s existing equity compensation plans, or changes in the number of outstanding shares of Common Stock due to the issuance of shares upon the exercise, vesting or conversion of securities exercisable for, or convertible into, shares of Common Stock outstanding on the date hereof or described in the Registration Statement, the General Disclosure Package and the Prospectus (including the documents incorporated or deemed incorporated by reference therein at such time pursuant to Item 12 of Form S-3 under the 1933 Act and the documents otherwise deemed to be a part thereof as of such time pursuant to Rule 430B or as a result of the issuance of Securities)) and such </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">authorized capital stock conforms in all material respects to the description thereof set forth in the Registration Statement and the Prospectus (including the documents incorporated or deemed incorporated by reference therein at such time pursuant to Item 12 of Form S-3 under the 1933 Act and the documents otherwise deemed to be a part thereof as of such time pursuant to Rule 430B).  The description of the Securities in the Registration Statement, the General Disclosure Package and the Prospectus is complete and accurate in all material respects.  Other than as set forth or described in the Registration Statement, the General Disclosure Package and the Prospectus (including the documents incorporated or deemed to be incorporated by reference therein), as of the dates referred to therein, the Company did not have outstanding any options to purchase, or any rights or warrants to subscribe for, or any securities or obligations convertible into, or exchangeable for, or any contracts or commitments to issue or sell, any shares of capital stock or other securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">  </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Authorization of Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company has full legal right, power and authority to enter into this Agreement and perform the transactions contemplated hereby.  This Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding agreement of the Company enforceable against the Company in accordance with its terms except to the extent that (i) enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#x2019; rights generally and by general equitable principles and (ii) the indemnification and contribution provisions of Section 6 hereof may be limited by federal or state securities laws and public policy considerations in respect thereof.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xiii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Authorization and Description of Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Securities to be purchased by the Underwriters from the Company have been duly authorized for issuance and sale to the Underwriters pursuant to this Agreement and, when issued and delivered by the Company pursuant to this Agreement against payment of the consideration set forth herein, will be validly issued and fully paid and non-assessable, free and clear of any pledge, lien, encumbrance, security interest or other claim, including any statutory or contractual preemptive rights, resale rights, rights of first refusal or other similar rights, and will be registered pursuant to Section 12 of the 1934 Act. The Pre-Funded Warrants in the form attached hereto as Exhibit B have been duly authorized by the Company and, when executed and delivered by the Company in accordance with this Agreement, will constitute valid and legally binding agreements of the Company, enforceable against the Company in accordance with their terms, except as enforceability may be limited by applicable bankruptcy, insolvency or similar laws affecting creditors&#x2019; rights generally or by equitable principles relating to enforceability. The Warrant Shares have been duly authorized and validly reserved for issuance upon exercise of the Pre-Funded Warrants in a number sufficient to meet the current exercise requirements. The Warrant Shares, when issued and delivered upon exercise of the Pre-Funded Warrants in accordance therewith, will be validly issued, fully paid and non-assessable, and the issuance of the Warrant Shares is not subject to any preemptive or other similar rights to subscribe for or purchase the Warrant Shares. The Securities conform to all statements relating thereto contained in the Registration Statement, the General Disclosure Package </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">8</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">and the Prospectus and such description conforms to the rights set forth in the instruments defining the same.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xiv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Registration Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  There are no persons with registration rights or other similar rights to have any securities registered for sale pursuant to the Registration Statement or otherwise registered for sale or sold by the Company under the 1933 Act pursuant to this Agreement.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Absence of Violations, Defaults and Conflicts</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company is not (A) in violation of its charter or bylaws or similar organizational documents, (B) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company is a party or by which the Company is bound or to which any of the property or assets of the Company is subject (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Agreements and Instruments</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), except for such default that would not, singly or in the aggregate, result in a Material Adverse Effect, or (C) in violation of any law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or agency having jurisdiction over the Company or any of its properties, assets or operations (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Governmental Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), except for such violations that would not, singly or in the aggregate, result in a Material Adverse Effect.  The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated herein and in the Registration Statement, the General Disclosure Package and the Prospectus (including the issuance and sale of the Securities and the Warrant Shares and the use of the proceeds from the sale of the Securities as described therein under the caption &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Use of Proceeds</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) and compliance by the Company with its obligations hereunder have been duly authorized by all necessary corporate action and do not and will not, whether with or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Company pursuant to, the Agreements and Instruments (except for such conflicts, breaches, defaults or Repayment Events or liens, charges or encumbrances that would not, singly or in the aggregate, result in a Material Adverse Effect), nor will such action result in any violation of (i) the provisions of the charter or by-laws of the Company or (ii) any law, statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity except, in the case of clause (ii), for any such violation that would not, singly or in the aggregate, result in a Material Adverse Effect.  As used herein, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Repayment Event</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder&#x2019;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xvi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Absence of Labor Dispute</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  No labor dispute with the employees of the Company exists or, to the knowledge of the Company, is threatened which would reasonably be expected to result in a Material Adverse Effect.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">9</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xvii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Absence of Proceedings</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, there are no legal, governmental or regulatory actions, suits or proceedings pending, nor, to the Company&#x2019;s knowledge, any legal, governmental or regulatory investigations, to which the Company is a party or to which any property of the Company is the subject that, individually or in the aggregate, if determined adversely to the Company, would reasonably be expected to have a Material Adverse Effect or materially and adversely affect the ability of the Company to perform its obligations under this Agreement; to the Company&#x2019;s knowledge, no such actions, suits or proceedings are threatened or contemplated by any governmental or regulatory authority or threatened by others that, individually or in the aggregate, if determined adversely to the Company, would reasonably be expected to have a Material Adverse Effect; and (i) there are no current or pending legal, governmental or regulatory actions, suits or proceedings or, to the Company&#x2019;s knowledge, investigations that are required under the 1933 Act to be described in the Registration Statement, the General Disclosure Package and Prospectus that are not described in the Registration Statement, the General Disclosure Package and Prospectus including any the documents incorporated or deemed to be incorporated by reference therein; and (ii) there are no contracts or other documents that are required under the 1933 Act to be filed as exhibits to the Registration Statement that are not so filed.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xviii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Accuracy of Exhibits</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  There are no contracts or documents which are required to be described in the Registration Statement, the General Disclosure Package or the Prospectus or to be filed as exhibits to the Registration Statement which have not been so described and filed as required.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xix)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Absence of Further Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  No filing with, or authorization, approval, consent, license, order, registration, qualification or decree of, any Governmental Entity is necessary or required for the performance by the Company of its obligations hereunder, in connection with the offering, issuance or sale of the Securities hereunder or the consummation of the transactions contemplated by this Agreement, except such as have been already obtained or as may be required under the 1933 Act, the 1933 Act Regulations, the rules of the Nasdaq Stock Market LLC, state securities laws or the rules of Financial Industry Regulatory Authority, Inc. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">FINRA</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;).</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xx)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Possession of Licenses and Permits</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company possesses or has obtained, and is and has been in compliance with the terms of, all licenses, certificates, consents, orders, approvals, permits and other authorizations issued by, and has made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of its properties or the business of the Company as currently conducted by it as described in the Registration Statement and the Prospectus (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Permits</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), except where the failure to possess, obtain, comply with or make the same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.  All such Permits are in full force and effect, and the Company has not received written notice of any proceeding relating to revocation or modification of any such Permit nor has any reason to believe that such Permit will not be renewed in the ordinary course, and to the Company&#x2019;s </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">10</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">knowledge, no event has occurred, which allows, or after notice or lapse of time would allow, revocation or termination thereof or results in any other material impairment of the rights of the holder of any such Permit, except in each case,  except where such impairment or termination, or the failure to obtain any such renewal would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Studies, Tests and Trials.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">  The clinical and preclinical studies, tests and trials conducted by or on behalf of or sponsored by the Company, or in which the Company has participated with respect to its product candidates including, without limitation, any such studies, tests or trials  that are described in, or the results of which are referred to in, the Registration Statement, the General Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with all applicable laws, rules, and regulations to which they are subject, including without limitation all applicable Health Care Laws (as defined below).The description of the results of the studies, tests and trials contained in the Registration Statement, the General Disclosure Package and the Prospectus are accurate in all material respects, and the Company has no knowledge of any other studies, tests or trials, the results of which could reasonably be expected to call into question in any material respect the results described in the Registration Statement, the General Disclosure Package and the Prospectus. The Company has made all such material filings and obtained all such allowances or approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">FDA</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) or any committee thereof or from any other U.S. or foreign government regulatory agency, or health care facility Institutional Review Board (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Regulatory Agencies</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) for the conduct of such studies, tests or trials, and the Company has not received any written notice of, or correspondence from, any Regulatory Agency  requiring the termination, suspension or modification of any studies, tests or trials, other than ordinary course written communications with respect to modifications in connection with the design and implementation of such tests or trials, and, to the Company&#x2019;s knowledge, there are no reasonable grounds for the same</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Title to Property</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company has good and marketable title in fee simple to all items of real property and good and valid title to all personal property (excluding Intellectual Property, as defined below) described in the Registration Statement, the General Disclosure Package and the Prospectus as being owned by it that are material to the business of the Company, in each case free and clear of all liens, encumbrances and claims, except those that (i) do not materially interfere with the use made of such property by the Company or (ii) would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.  Any real property described in the Registration Statement, the General Disclosure Package or Prospectus as being leased by the Company is held by the Company under valid, existing and enforceable leases, except those that (A) do not materially interfere with the use made or proposed to be made of such property by the Company or (B) would not be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect. </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">11</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxiii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Possession of Intellectual Property</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company owns, possesses valid and enforceable licenses for, or can acquire on reasonable terms by ownership or license all trademarks, trade names, patent rights, copyrights, domain names, licenses, approvals, trade secrets, inventions, technology, know-how and other intellectual property and similar rights, including registrations and applications for registration thereof (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Intellectual Property Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) necessary for, or material to the conduct of the business of the Company as now conducted or proposed in the Registration Statement and the Prospectus to be conducted by them.  Except as disclosed in the Registration Statement and the Prospectus: </font></div></div>
  <p style="margin-left:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(a) there are no ownership rights of third parties to any of the Intellectual Property Rights purported to be owned solely by the Company;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(b) the Company is not aware of any infringement, misappropriation, breach, default or other violation, or the occurrence of any event that would result in any of the foregoing, by any third parties of any of the Intellectual Property Rights owned by or licensed to the Company;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(c) there are no pending or threatened actions, suits, proceedings or claims by others challenging the Company&#x2019;s rights in or to, or the violation of any of the terms of, any Intellectual Property Rights owned by or licensed to the Company, and the Company is unaware of any facts which would form a reasonable basis for any such claim;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(d) there are no pending or threatened actions, suits, proceedings or claims by others challenging the validity, enforceability or scope of any Intellectual Property Rights owned by or licensed to the Company, and the Company is unaware of any facts which would form a reasonable basis for any such claim; and</font></p>
  <p style="margin-left:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(e) there are no pending or threatened actions, suits, proceedings or claims by others that the Company infringes, misappropriates or otherwise violates or conflicts with any Intellectual Property Rights or other proprietary rights of others and the Company is unaware of any other fact which would form a reasonable basis for any such claim, except as would not individually or in the aggregate be material to the conduct of the business now conducted or proposed by the Registration Statement and the Prospectus to be conducted by the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Further, except as disclosed in the Registration Statement and the Prospectus, none of the Intellectual Property Rights used by the Company in its businesses has been obtained or is being used by the Company in violation of any contractual obligation binding on the Company in violation of the rights of any persons.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company is the sole owner of the Intellectual Property Rights solely owned by it and has the valid and enforceable right to use such Intellectual Property Rights without the obligation to obtain consent to sublicense and without a duty of accounting to co-owner, as applicable.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">12</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Except as disclosed in the Registration Statement and the Prospectus, the Company is not obligated to pay a material royalty, grant a license or option, or provide other material consideration to any third party in connection with the Intellectual Property Rights owned by or licensed to the Company.  The Company has complied with the terms of each agreement pursuant to which Intellectual Property Rights have been licensed to the Company, and all such agreements are in full force and effect.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">  </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company has taken all reasonable steps necessary to secure assignments to its respective title, rights and interests in and to the Intellectual Property Rights purported to be owned by the Company from its employees, consultants, agents and contractors.  All employees, consultants, agents and contractors engaged in the development of Intellectual Property Rights on behalf of the Company have executed appropriate invention assignment agreements or terms whereby such employees, consultants, agents and contractors presently assign all of their right, title and interest in and to such Intellectual Property Rights to the Company, and to the Company&#x2019;s knowledge, no such agreement has been breached or violated.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">To the Company&#x2019;s knowledge, no employee of the Company is in or has been in violation of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&#x2019;s employment with the Company, except as would not, singly or in the aggregate, result in a Material Adverse Effect.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">  </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company uses, and has used, commercially reasonable efforts to appropriately maintain all information intended to be maintained as a trade secret.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">  </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company has complied with the terms of each agreement pursuant to which Intellectual Property Rights have been licensed to the Company, and all such agreements are in full force and effect.  Imetelstat, the product candidate described in the Registration Statement and the Prospectus as under development by the Company, falls within the scope of the claims of one or more patents or patent applications owned by the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Except as described in the Registration Statement and the Prospectus, no government funding, facilities or resources of a university, college, other educational institution or research center, was used in the development of any Intellectual Property Rights that are owned or purported to be owned by the Company that would confer any governmental agency any claim or right of ownership to any such Intellectual Property Rights.</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxiv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Patents and Patent Applications</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  All patents and patent applications owned by or, to the knowledge of the Company, exclusively licensed to the Company have been duly and properly filed and each issued patent is being diligently maintained and is valid and enforceable; and </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">13</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(a) the Company is not aware of any facts that would preclude the issuance of a valid and enforceable patent on any pending patent applications owned by or licensed to the Company;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(b) to the knowledge of the Company, the Company and the parties prosecuting such applications have complied with their duty of candor and disclosure to the U.S. Patent and Trademark Office (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">USPTO</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), and all such requirements in the relevant foreign patent authority having similar requirements as the case may be, in connection with such patents and patent applications for which it has filing, prosecution and/or maintenance responsibilities;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(c) to the Company&#x2019;s knowledge, there is no patent that contains claims that dominate (as such term is described in 35 U.S.C. &#167;135 and 37 C.F.R. 41.100 to 41.208) with the issued or pending claims of any of the Intellectual Property Rights owned by or licensed to the Company;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(d) to the Company&#x2019;s knowledge, there is no prior art material to any patent or patent application of the Intellectual Property Rights owned by or licensed to the Company that may render any U.S. patent or any U.S. patent issuing from a U.S. patent application held by the Company invalid or unenforceable; and</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(e) the Company is not aware of any prior art or public or commercial activity or other facts required to be disclosed to the USPTO and any relevant foreign patent authority that were not disclosed and which would preclude the grant of a patent in connection with any such application or would reasonably be expected to form the basis of a finding of invalidity or unenforceability with respect to any patents that have been issued with respect to such applications.</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Environmental Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Except as described in the Registration Statement, the General Disclosure Package and the Prospectus or except as would not, singly or in the aggregate, result in a Material Adverse Effect, (A) the Company is in compliance with all applicable federal, state, local and foreign laws, rules, regulations, decisions and orders relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Environmental Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), (B) the Company has all permits, licenses or other approvals required under any applicable Environmental Laws and is in compliance with their requirements, (C) has not received notice of any actual or potential liability for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, except, in the case of any of clauses (A) or (B) above, for any such failure to comply or failure to receive required permits, licenses, other approvals or liability as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxvi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Health Care Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.   The Company is, and at all times has been, in compliance with all applicable Health Care Laws except where the failure to be in compliance would not, individually or in the aggregate, result in a Material Adverse Effect.  For purposes of this Agreement, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Health Care Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; means (A) the Federal Food, Drug, and Cosmetic Act, and the regulations promulgated thereunder, (B) federal and state fraud and abuse laws, including, the federal Anti-Kickback </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Statute (42 U.S.C. &#167;1320a-7b(b)), the civil False Claims Act (31 U.S.C. &#167;3729 </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">et seq</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.), Sections 1320a-7 and 1320a-7a of Title 42 of the United States Code, the criminal false statements law (42 U.S.C. Section 1320a-7b(a)), 18 U.S.C. Sections 286, 287, 1349 and the health care fraud criminal provisions under the U.S. Health Insurance Portability and Accountability Act of 1996 (&#x201c;HIPAA&#x201d;) (42 U.S.C. Section 1320d et seq.), the Physician Payments Sunshine Act (42 U.S.C. Section 1320-7h), and the regulations promulgated pursuant to such statutes, (C) HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. Section 17921 et seq.) and the regulations promulgated thereunder, (D) Titles XVII (42 U.S.C. &#167;1395 </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">et seq</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.) and XIX (42 U.S.C. &#167;1396 </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">et seq</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.) of the Social Security Act and the regulations promulgated thereunder, and any applicable laws governing government funded or sponsored healthcare programs (E) the Patient Protection and Affordable Care Act, (F) all statutes, directives, rules or regulations applicable to the ownership, testing, development, manufacture, quality, safety, accreditation, packaging, use, distribution, labeling, promotion, sale, offer for sale, import, export or disposal of any product or product candidate manufactured, developed, tested, imported, exported, advertised, promoted, sold or distributed by the Company applicable to the business of the Company as currently conducted by it as described in the Registration Statement; (G) any and all other health care laws and regulations applicable to the business of the Company as currently conducted by it as described in the Registration Statement, the General Disclosure Package and the Prospectus, each of (A) through (G) as may be amended from time to time. The Company has not received any FDA Form-483, written notice of adverse finding, warning letter, untitled letter or other correspondence or written notice from any court or arbitrator or Governmental Entity or regulatory authority alleging or asserting material non-compliance by the Company with any applicable Health Care Laws or Permits required by any such Health Care Laws. The Company has not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or governmental or regulatory authority or third party alleging that any product operation or activity of the Company is in material violation of any applicable Health Care Laws nor, to the Company&#x2019;s knowledge, is any such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action threatened.  The Company has filed, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Health Care Laws, and all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and accurate on the date filed in all material respects (or were corrected or supplemented by a subsequent submission), except where the failures to file, maintain or submit the same would not, whether individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.  The Company is not a party to any corporate integrity agreements, deferred or non-prosecution agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory authority except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus.  Additionally, neither the Company nor any of its respective employees, officers, directors, or, to the knowledge of the Company, agents has been excluded, suspended or debarred from participation in any U.S.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">15</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">federal health care program or human clinical research or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment, suspension, or exclusion.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxvii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Accounting Controls and Disclosure Controls</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company maintains a system of internal accounting controls designed to provide reasonable assurances that:  (A) transactions are executed in accordance with management&#x2019;s general or specific authorization; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (C) access to assets is permitted only in accordance with management&#x2019;s general or specific authorization; and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.  The interactive data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#x2019;s rules and guidelines applicable thereto.  The Company is not aware of any material weaknesses in its internal control over financial reporting.  Since the date of the latest audited financial statements of the Company included in the Prospectus, there has been (1) no material weakness in the Company&#x2019;s internal control over financial reporting (whether or not remediated) and (2) no change in the Company&#x2019;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#x2019;s internal control over financial reporting (other than as set forth in the Registration Statement, the General Disclosure Package and the Prospectus).  The Company maintains an effective system of disclosure controls and procedures (as defined in Rule 13a-15 and Rule 15d-15 under the 1934 Act Regulations) that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#x2019;s rules and forms, and is accumulated and communicated to the Company&#x2019;s management, including its principal executive officer or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding disclosure.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxviii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Payment of Taxes</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company has filed all federal, state, local and foreign income, property and franchise tax returns which have been required to be filed and paid all taxes required to be paid through the date hereof and, to the extent that such taxes have become due and payable, any related or similar assessment, fine or penalty levied against them by a taxing authority, except, in each case, (A) as are being contested in good faith or (B) where the failure to do so would not reasonably be expected to have a Material Adverse Effect.  No tax deficiency has been determined adversely to the Company which has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.  The Company has no knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been asserted or threatened against it which would have a Material Adverse Effect. The Company has made adequate charges, accruals and reserves in the applicable financial statements referred to in Section 1(vii) above in respect of all </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">16</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">federal, state and foreign income, property and franchise taxes for all periods as to which the tax liability of the Company or any of its subsidiaries has not been finally determined except where the failure to do so would not reasonably be expected to have a Material Adverse Effect.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxix)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Insurance</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company carries, or is covered by, insurance in such amounts and covering such risks as the Company reasonably believes are adequate for the use of its properties and as is customary for companies of similar size engaged in similar businesses in similar industries.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxx)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Investment Company Act</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company is not required, and upon the issuance and sale of the Securities as herein contemplated and the application of the net proceeds therefrom as described in the Registration Statement, the General Disclosure Package and the Prospectus will not be required, to register as an &#x201c;investment company&#x201d; under the Investment Company Act of 1940, as amended (the &#x201c;1940 Act&#x201d;).</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxxi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Absence of Manipulation</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Neither the Company nor, to the knowledge of the Company, any of its affiliates has taken, or will take, directly or indirectly, any action which constitutes, or might reasonably be expected, to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities or to result in a violation of Regulation M under the 1934 Act.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxxii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Foreign Corrupt Practices Act</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  None of the Company or, to the knowledge of the Company, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company or any of its subsidiaries is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">FCPA</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#x201c;foreign official&#x201d; (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxxiii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Money Laundering Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The operations of the Company are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Money Laundering Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;); and no action, suit or proceeding by or before any Governmental Entity involving the Company with respect to the </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">17</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxxiv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">OFAC</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Neither the Company nor, to the knowledge of the Company, any director, officer, agent, employee, affiliate or representative of the Company is an individual or entity (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) currently the subject or target, or is owned or controlled by a Person that is, of any sanctions administered or enforced by the United States Government, including, without limitation, the U.S. Department of the Treasury&#x2019;s Office of Foreign Assets Control (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">OFAC</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), the United Nations Security Council (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">UNSC</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), the European Union, His Majesty&#x2019;s Treasury (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">HMT</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), the Swiss Secretariat of Economic Affairs or other relevant sanctions authority (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Sanctions</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), nor is the Company located, organized or resident in a country or territory that is the subject of comprehensive Sanctions (currently, the so-called Donetsk People's Republic, the so-called Luhansk People's Republic, the Crimea regions of Ukraine, the non-government controlled areas of the Zaporizhzhia and Kherson Regions, Cuba, Iran, Syria and North Korea); and the Company will not directly or indirectly use the proceeds of the sale of the Securities, or lend, contribute or otherwise make available such proceeds to any subsidiaries, joint venture partners or other Person, to fund any activities of or business with any Person, or in any country or territory, that, at the time of such funding, is the subject of Sanctions prohibiting such funding or in any other manner that will result in a violation by any Person (including any Person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions.  The Company represents and covenants that, except as detailed in the Prospectus, for the past five years, the Company has not knowingly engaged in, is not now knowingly engaged in, and will not knowingly engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions prohibiting such dealings or transactions.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxxv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Lending Relationship</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the Company (i) does not have any material lending or other relationship with any bank or lending affiliate of any Underwriter and (ii) does not intend to use any of the proceeds from the sale of the Securities to repay any outstanding debt owed to any affiliate of any Underwriter.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxxvi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Statistical and Market-Related Data</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Any statistical and market-related data included in the Registration Statement, the General Disclosure Package or the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate and, to the extent required, the Company has obtained the written consent to the use of such data from such sources.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxxvii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">No Rated Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company has no debt securities or preferred stock that is rated by any &#x201c;nationally recognized statistical rating agency&#x201d; (as that term is defined by the Commission for purposes of Rule 436(g)(2) under the 1933 Act).</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">18</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxxviii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Information Technology</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Except as would not, singly or in the aggregate, have a Material Adverse Effect, the Company&#x2019;s information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">IT Systems</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) are adequate for, and operate and perform as required in connection with the operation of the business of the Company as currently conducted, and to the knowledge of the Company are free and clear of all bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants.  For purpose of clarity, any third-party information technology systems over which the Company does not exercise control shall not be deemed to be the Company&#x2019;s IT Systems.  The Company has implemented and maintained or caused to be implemented and maintained commercially reasonable controls, policies, procedures, and safeguards designed to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all of the Company&#x2019;s IT Systems, and the confidentiality of any personal, personally identifiable, sensitive, confidential or regulated data from which a person can be identified or potentially identified (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Personal Data</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;)) used in connection with its businesses, and to the Company&#x2019;s knowledge and except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, there have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigation relating to the same.  Except as would not result in a Material Adverse Effect, the Company has, for the past three (3) years, and is presently in compliance with all applicable laws or statutes and all applicable judgments, orders, binding rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and material contractual obligations, in each of the foregoing cases as relating to the privacy and security of the Company&#x2019;s IT Systems and Personal Data and to the protection of such IT Systems and Personal Data used in connection with its business from unauthorized use, access, misappropriation or modification.  Except as would not result in a Material Adverse Effect, the Company has taken all necessary actions to comply with the European Union General Data Protection Regulation and all other applicable privacy laws and regulations with respect to Personal Data used in connection with its business.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xxxix)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Forward-Looking Statements.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> No forward-looking statement (within the meaning of Section 27A of the Act and Section 21E of the Exchange Act) included or incorporated by reference in any of the Registration Statement or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xl)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Maintenance of Registration</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">. The Company shall, at all times while the Company is subject to the reporting requirements of Section 13 or 15(d) of the 1934 Act and any Pre-Funded Warrants are outstanding, use its commercially reasonable efforts to maintain a registration statement covering the issuance and sale of the Warrant Shares upon exercise of the Pre-Funded Warrants, when issued, will not be subject to resale and restrictions under the 1933 Act except to the extent that the Pre-Funded Warrants are owned by affiliates.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">19</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xli)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Warrant Shares Reserved</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">. The Company shall, at all times while any Pre-Funded Warrants are outstanding, reserve and keep available out of the aggregate of its authorized but unissued and otherwise unreserved shares of Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of such Pre-Funded Warrants, the number of Warrant Shares that are initially issuable and deliverable upon the exercise of the then-outstanding Pre-Funded Warrants.</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(xlii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Officer&#x2019;s Certificates</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Any certificate signed by any officer of the Company delivered to the Representatives or to counsel for the Underwriters shall be deemed a representation and warranty by the Company to each Underwriter as to the matters covered thereby.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Sale and Delivery to Underwriters; Closing.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Common Stock Securities and Pre-Funded Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, the Company agrees to sell to each Underwriter, severally and not jointly, and each Underwriter, severally and not jointly, agrees to purchase from the Company, at the price per share set forth in Schedule A, that proportion of the number of Common Stock Securities and Pre-Funded Warrants set forth in Schedule A opposite the name of such Underwriter, plus any additional number of Common Stock Securities and Pre-Funded Warrants which such Underwriter may become obligated to purchase pursuant to the provisions of Section 10 hereof, subject, in each case, to such adjustments among the Underwriters as the Representatives in their sole discretion shall make to eliminate any sales or purchases of fractional shares.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">[Reserved]</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Payment</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Payment of the purchase price for, and delivery of certificates or security entitlements for, the Common Stock Securities and the Pre-Funded Warrants shall be made at the offices of Latham &amp; Watkins LLP, 140 Scott Dr, Menlo Park, CA 94025, or at such other place as shall be agreed upon by the Representatives and the Company, at 10:00 A.M. (New York City time) on the second (third, if the pricing occurs after 4:30 P.M. (New York City time) on any given day) business day after the date hereof (unless postponed in accordance with the provisions of Section 10), or such other time not later than ten business days after such date as shall be agreed upon by the Representatives and the Company (such time and date of payment and delivery being herein called &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Closing Time</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;). Delivery of the Common Stock Securities at the Closing Time shall be made through the facilities of The Depository Trust Company unless the Representatives shall otherwise instruct. The Pre-Funded Warrants shall be delivered to the purchasers of the Pre-Funded Warrants in definitive form, registered in such names and in such denominations as the purchasers of the Pre-Funded Warrants shall request in writing not later than the Closing Time. The Pre-Funded Warrants will be made available for inspection by the Representatives on the business day prior to the Closing Time. The Company and the Representatives shall instruct purchasers of the Pre-Funded Warrants to make payment for the Pre-Funded Warrants on the Closing Time to the Company by wire transfer in immediately available funds to the account specified by the Company at a purchase price of $2.999 per Pre-Funded Warrant, in lieu of payment by the Underwriters for such Pre-Funded Warrants, and the Company shall deliver such </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">20</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Pre-Funded Warrants to such purchasers on the Closing Time in definitive form against such payment, in lieu of the Company&#x2019;s obligation to deliver such Pre-Funded Warrants to the Underwriters; provided that the Company shall promptly (but in no event later than the Closing Time) pay $0.18 per such Pre-Funded Warrant to the Underwriters by wire transfer in immediately available funds to the account specified by the Representatives. In the event that the purchasers of the Pre-Funded Warrants fail to make payment to the Company for all or part of the Pre-Funded Warrants on the Closing Time, the Representatives may elect, by written notice to the Company, to receive shares of Common Stock in lieu of all or a portion of such Pre-Funded Warrants to be delivered to the Underwriters under this Agreement.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Payment shall be made to the Company by wire transfer of immediately available funds to a bank account designated by the Company, against delivery to the Representatives for the respective accounts of the Underwriters of certificates or security entitlements for the Securities to be purchased by them.  It is understood that each Underwriter has authorized the Representatives, for its account, to accept delivery of, receipt for, and make payment of the purchase price for, the Common Stock Securities and the Pre-Funded Warrants which it has agreed to purchase.  The Representatives, each individually and not as representatives of the Underwriters, may (but shall not be obligated to) make payment of the purchase price for the Common Stock Securities or the Pre-Funded Warrants to be purchased by any Underwriter whose funds have not been received by the Closing Time, but such payment shall not relieve such Underwriter from its obligations hereunder.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Covenants of the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company covenants with each Underwriter as follows:</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Compliance with Securities Regulations and Commission Requests</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company, subject to Section 3(b), will comply with the requirements of Rule 430B, and will notify the Representatives immediately, and confirm the notice in writing, (i) when any post-effective amendment to the Registration Statement shall become effective or any amendment or supplement to the Prospectus shall have been filed, (ii) of the receipt of any comments from the Commission, (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus, including any document incorporated by reference therein or for additional information, (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment or of any order preventing or suspending the use of the Base Prospectus or the Prospectus, or of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes or of any examination pursuant to Section 8(d) or 8(e) of the 1933 Act concerning the Registration Statement and (v) if the Company becomes the subject of a proceeding under Section 8A of the 1933 Act in connection with the offering of the Securities.  The Company will effect all filings required under Rule 424(b), in the manner and within the time period required by Rule 424(b) (without reliance on Rule 424(b)(8)), and will take such steps as it deems necessary to ascertain promptly whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not, it will promptly file such prospectus.  The Company will make every reasonable effort to prevent the issuance of any stop order, prevention or suspension and, if any such order is issued, to obtain the lifting thereof at the earliest possible </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">21</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">moment.  The Company shall pay the required Commission filing fees relating to the Securities within the time required by Rule 456(b)(1)(i) under the 1933 Act Regulations without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) under the 1933 Act Regulations (including, if applicable, by updating the &#x201c;Calculation of Registration Fee&#x201d; table in accordance with Rule 456(b)(1)(ii) either in a post-effective amendment to the Registration Statement or on the cover page of a prospectus filed pursuant to Rule 424(b)).</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Continued Compliance with Securities Laws</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company will comply with the 1933 Act, the 1933 Act Regulations, the 1934 Act and the 1934 Act Regulations so as to permit the completion of the distribution of the Securities as contemplated in this Agreement and in the Registration Statement, the General Disclosure Package and the Prospectus.  If at any time when a prospectus relating to the Securities is (or, but for the exception afforded by Rule 172 of the 1933 Act Regulations (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Rule 172</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), would be) required by the 1933 Act to be delivered in connection with sales of the Securities, any event shall occur or condition shall exist as a result of which it is necessary, in the opinion of counsel for the Underwriters or for the Company, to (i) amend the Registration Statement in order that the Registration Statement will not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii) amend or supplement the General Disclosure Package or the Prospectus in order that the General Disclosure Package or the Prospectus, as the case may be, will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances existing at the time it is delivered to a purchaser or (iii) amend the Registration Statement or amend or supplement the General Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements of the 1933 Act or the 1933 Act Regulations, the Company will promptly (A) give the Representatives notice of such event, (B) prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the Registration Statement, the General Disclosure Package or the Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed filing or use, furnish the Representatives with copies of any such amendment or supplement and (C) file with the Commission any such amendment or supplement; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">provided </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that the Company shall not file or use any such amendment or supplement to which the Representatives or counsel for the Underwriters shall object.  The Company will furnish to the Underwriters such number of copies of such amendment or supplement as the Underwriters may reasonably request.  The Company has given the Representatives notice of any filings made pursuant to the 1934 Act or 1934 Act Regulations within 48 hours prior to the Applicable Time; the Company will give the Representatives notice of its intention to make any such filing from the Applicable Time to the Closing Time and will furnish the Representatives with copies of any such documents a reasonable amount of time prior to such proposed filing, as the case may be, and will not file or use any such document to which the Representatives or counsel for the Underwriters shall reasonably object.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Delivery of Registration Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  If requested, the Company has furnished or will deliver to the Representatives and counsel for the Underwriters, without charge, signed copies of the Registration Statement as originally filed and each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates of experts, and will also deliver to the Representatives, without charge, a conformed copy </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">22</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">of the Registration Statement as originally filed and each amendment thereto (without exhibits) for each of the Underwriters.  The copies of the Registration Statement and each amendment thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Delivery of Prospectuses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company will furnish to each Underwriter, without charge, during the period when a prospectus relating to the Securities is (or, but for the exception afforded by Rule 172, would be) required to be delivered under the 1933 Act, such number of copies of the Prospectus (as amended or supplemented) as such Underwriter may reasonably request.  The Prospectus and any amendments or supplements thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Blue Sky Qualifications</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company will use its reasonable best efforts, in cooperation with the Underwriters, to qualify the Securities for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Representatives may designate and to maintain such qualifications in effect so long as required to complete the distribution of the Securities; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;"> however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Rule 158</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company will timely file such reports pursuant to the 1934 Act as are necessary in order to make generally available to its securityholders as soon as practicable an earnings statement for the purposes of, and to provide to the Underwriters the benefits contemplated by, the last paragraph of Section 11(a) of the 1933 Act.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Use of Proceeds</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company will use the net proceeds received by it from the sale of the Securities in the manner specified in the Registration Statement, the General Disclosure Package and the Prospectus under &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Use of Proceeds.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Listing</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company will use its best efforts to effect and maintain the listing of the Common Stock (including the Securities) on the Nasdaq Global Select Market.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Restriction on Sale of Securities.  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">During a period of 75 days from the date of the Prospectus, the Company will not, without the prior written consent of TD Cowen (or an affiliate thereof) and Stifel, (i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or file any registration statement under the 1933 Act with respect to any of the foregoing or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the Common Stock, whether any such swap or transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The foregoing sentence shall not apply to (A) the Securities to be sold hereunder, (B) any shares of Common Stock issued by the </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">23</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Company upon the exercise, settlement or vesting of any warrant, right, option, restricted stock unit or other equity award, or the conversion of a security outstanding on the date hereof and referred to in the Registration Statement, the General Disclosure Package and the Prospectus, (C) any shares of Common Stock issued, or any options to purchase Common Stock, restricted stock units or other equity awards granted, in each case pursuant to existing equity compensation plans or arrangements of the Company referred to in the Registration Statement, the General Disclosure Package and the Prospectus, (D) any shares of Common Stock issued pursuant to existing defined-contribution savings plans under Section 401(k) of the Internal Revenue Code (including any shares issued as Company matching contributions) referred to in the Registration Statement, the General Disclosure Package and the Prospectus, (E) any shares of Common Stock issued pursuant to any non-employee director stock plan or dividend reinvestment plan referred to in the Registration Statement, the General Disclosure Package and the Prospectus, (F) any shares of Common Stock issued to one or more counterparties in connection with the consummation of any strategic partnership, joint venture, collaboration or other strategic transaction, or the acquisition or license of any business products or technology, provided that the aggregate number of shares that the Company may sell or issue or agree to sell or issue pursuant to this clause (F) shall not exceed 5% of the total number of shares of the Company&#x2019;s Common Stock issued and outstanding immediately following the completion of the transactions contemplated by this Agreement, or (G) the filing of any registration statement on Form S-8 (including any post-amendments to any such registration statement) in respect of any equity compensation plans or arrangements maintained by the Company. In addition, notwithstanding anything to the contrary contained in this Section 3(i), the Company shall be permitted to keep in effect the At Market Issuance Sales Agreement, dated November 1, 2023, by and between the Company and B. Riley Securities, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">B. Riley Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;"> however </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that no sales of Common Stock under the B. Riley Agreement shall be made during the 75-day restricted period.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Reporting Requirements</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company, during the period when a Prospectus relating to the Securities is (or, but for the exception afforded by Rule 172, would be) required to be delivered under the 1933 Act, will file all documents required to be filed with the Commission pursuant to the 1934 Act within the time periods required by the 1934 Act and 1934 Act Regulations.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Issuer Free Writing Prospectuses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company agrees that, unless it obtains the prior written consent of the TD Cowen (or an affiliate thereof) and Stifel, it will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &#x201c;free writing prospectus,&#x201d; or a portion thereof, required to be filed by the Company with the Commission or retained by the Company under Rule 433; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">provided </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that the Representatives will be deemed to have consented to the Issuer Free Writing Prospectuses listed on Schedule B hereto and any &#x201c;road show that is a written communication&#x201d; within the meaning of Rule 433(d)(8)(i) that has been reviewed by the Representatives.  The Company represents that it has treated or agrees that it will treat each such free writing prospectus consented to, or deemed consented to, by the Representatives as an &#x201c;issuer free writing prospectus,&#x201d; as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including timely filing with the Commission where required, legending and record keeping.  If at any time following issuance of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">24</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement, the Base Prospectus or the Prospectus or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representatives and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Certification Regarding Beneficial Owners. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company will deliver to the Representatives, on the date of execution of this Agreement, a properly completed and executed Certification Regarding Beneficial Owners of Legal Entity Customers, together with copies of identifying documentation, and the Company undertakes to provide such additional supporting documentation as the Representatives may reasonably request in connection with the verification of the foregoing certification.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Payment of Expenses.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company will pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including (i) the preparation, printing and filing of the Registration Statement (including financial statements and exhibits) as originally filed and each amendment thereto, (ii) the preparation, printing and delivery to the Underwriters of copies of each Issuer Free Writing Prospectus and the Prospectus and any amendments or supplements thereto and any costs associated with electronic delivery of any of the foregoing by the Underwriters to investors, (iii) the preparation, issuance and delivery of the certificates for the Securities to the Underwriters, including any stock or other transfer taxes and any documentary, stamp, registration or similar issuance tax or other duties payable upon the sale, issuance or delivery of the Securities to the Underwriters, including any interest and penalties (iv) the fees and disbursements of the Company&#x2019;s counsel, accountants and other advisors, (v) the fees and expenses of any transfer agent or registrar for the Securities, (vi) the costs and expenses of the Company relating to investor presentations on any &#x201c;road show&#x201d; undertaken in connection with the marketing of the Securities, including without limitation, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged by the Company in connection with the road show presentations, travel and lodging expenses of the representatives and officers of the Company and any such consultants, and the cost of aircraft and other transportation chartered in connection with the road show, (vii) the filing fees incident to, and the reasonable and reasonably-documented fees and disbursements of counsel to the Underwriters not to exceed $15,000, in connection with the review by FINRA of the terms of the sale of the Securities and the qualification of the Securities under securities laws in accordance with the provisions of Section 3(e) hereof and in connection with the preparation of the Blue Sky Survey and any supplement thereto, (viii) the fees and expenses incurred in connection with the listing of the Securities on the Nasdaq Global Select Market; and (ix) the costs and expenses (including, without limitation, any damages or other amounts payable in connection with legal or contractual liability) associated with the reforming of any contracts for sale of the Securities made by the Underwriters caused by a breach of the representation contained in the third sentence of Section 1(a)(ii).  It is understood that except as provided by this Section 4(a) and Section 4(b) hereof, the Underwriters will pay all of their costs and expenses, including fees and </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">25</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">disbursements of counsel to the Underwriters and any stock or other transfer taxes and any stamp or other duties payable upon the sale, issuance or delivery of the Securities by the Underwriters.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Termination of Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  If this Agreement is terminated by the Representatives prior to the payment and delivery of the Securities in accordance with the provisions of Section 5 (other than by reason of the failure to satisfy the condition set forth in Section 5(d) or termination pursuant to Sections 9(a)(i), 9(a)(ii), 9(a)(iv), 9(a)(v) and 9(a)(vi)), the Company shall reimburse the Underwriters for all of their out-of-pocket expenses actually incurred by them, including the reasonable and reasonably-documented fees and disbursements of counsel for the Underwriters.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Allocation of Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The provisions of this Section shall not affect any agreement that the Company may make for the sharing of such costs and expenses.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Conditions of Underwriters&#x2019; Obligations</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  </font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The obligations of the several Underwriters hereunder are subject to the accuracy of the representations and warranties of the Company contained herein or in certificates of any officer of the Company delivered pursuant to the provisions hereof, to the performance by the Company of its covenants and other obligations hereunder, and to the following further conditions:</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Effectiveness of Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Registration Statement has become effective and, at the Closing Time, no stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued under the 1933 Act, no order preventing or suspending the use of the Base Prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending or, to the Company&#x2019;s knowledge, contemplated; and the Company has complied with each request (if any) from the Commission for additional information.  The Company shall have paid the required Commission filing fees relating to the Securities within the time period required by Rule 456(b)(1)(i) under the 1933 Act Regulations without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) under the 1933 Act Regulations and, if applicable, shall have updated the &#x201c;Calculation of Registration Fee&#x201d; table in accordance with Rule 456(b)(1)(ii) either in a post-effective amendment to the Registration Statement or on the cover page of a prospectus filed pursuant to Rule 424(b).</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Opinion of Counsel for Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  At the Closing Time, the Representatives shall have received the opinion and negative assurance letter, each dated the Closing Time, of Cooley LLP, counsel for the Company, in form and substance satisfactory to the Representatives.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Opinion of Intellectual Property Counsel for Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  At the Closing Time, the Representatives shall have received the opinion, dated the Closing Time, of Bozicevic, Field &amp; Francis LLP, intellectual property counsel for the Company, in form and substance satisfactory to the Representatives.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Opinion of Counsel for Underwriters</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  At the Closing Time, the Representatives shall have received the opinion and negative assurance letter, each dated the Closing Time, </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">26</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">of Latham &amp; Watkins LLP, counsel for the Underwriters, in form and substance satisfactory to the Representatives, and such counsel shall have received such papers and information as they may reasonably request to enable them to pass upon such matters.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Officers&#x2019; Certificate</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  At the Closing Time, there shall not have been, since the date hereof or since the respective dates as of which information is given in the Registration Statement, the General Disclosure Package or the Prospectus, any material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company, whether or not arising in the ordinary course of business, and the Representatives shall have received a certificate of the Chief Executive Officer or the President of the Company and of the chief financial or chief accounting officer of the Company, dated the Closing Time, to the effect that (i) there has been no such material adverse change, (ii) the representations and warranties of the Company in this Agreement are true and correct with the same force and effect as though expressly made at and as of the Closing Time, (iii) the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied at or prior to the Closing Time, and (iv) no stop order suspending the effectiveness of the Registration Statement under the 1933 Act has been issued, no order preventing or suspending the use of the Base Prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending or, to their knowledge, contemplated.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Regulatory Certificate</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  At the Closing Time, the Representatives shall have received a regulatory certificate, dated the Closing Time, of the Chief Medical Officer of the Company, in form and substance satisfactory to the Representatives.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Accountant&#x2019;s Comfort Letter</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  At the time of the execution of this Agreement, the Representatives shall have received from Ernst &amp; Young LLP a letter, dated such date, in form and substance satisfactory to the Representatives, together with signed or reproduced copies of such letter for each of the other Underwriters containing statements and information of the type ordinarily included in accountants&#x2019; &#x201c;comfort letters&#x201d; to underwriters with respect to the financial statements and certain financial information contained in the Registration Statement, the General Disclosure Package and the Prospectus.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Bring-down Comfort Letter</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  At the Closing Time, the Representatives shall have received from Ernst &amp; Young LLP a letter, dated as of the Closing Time, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (g) of this Section, except that the specified date referred to shall be a date not more than three business days prior to the Closing Time.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Exchange Listing</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company shall have filed a Notification:  Listing of Additional Shares with the Nasdaq Stock Market to satisfy the Company&#x2019;s notification obligation under Nasdaq Listing Rule 5250(e)(2).</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Lock-up Agreements</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  At the date of this Agreement, the Representatives shall have received an agreement substantially in the form of Exhibit A hereto signed by the persons listed on Schedule C hereto.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">27</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">[Reserved]. </font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Additional Documents</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  At the Closing Time, counsel for the Underwriters shall have been furnished with such documents and opinions as they may require for the purpose of enabling them to pass upon the issuance and sale of the Securities as herein contemplated, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Securities as herein contemplated shall be reasonably satisfactory in form and substance to the Representatives and counsel for the Underwriters.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(m)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Termination of Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  If any condition specified in this Section shall not have been fulfilled when and as required to be fulfilled, this Agreement may be terminated by the Representatives by notice to the Company at any time at or prior to Closing Time, and such termination shall be without liability of any party to any other party except as provided in Section 4 and except that Sections 1, 6, 7, 8, 14, 15 and 16 shall survive any such termination and remain in full force and effect.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Indemnification</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">. </font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Indemnification of Underwriters</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Company agrees to indemnify and hold harmless each Underwriter, its affiliates (as such term is defined in Rule 501(b) under the 1933 Act (each, an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;)), its selling agents and each person, if any, who controls any Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act as follows:</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), including any information deemed to be a part thereof pursuant to Rule 430B, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading or arising out of any untrue statement or alleged untrue statement of a material fact included (A) in any preliminary prospectus, any Issuer Free Writing Prospectus, the General Disclosure Package or the Prospectus (or any amendment or supplement thereto) or (B) in any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Common Stock (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Marketing Materials</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), including any roadshow or investor presentations made to investors by the Company (whether in person or electronically), or the omission or alleged omission in any Issuer Free Writing Prospectus, Prospectus or in any Marketing Materials of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">against any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">28</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">omission; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">provided </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that (subject to Section 6(d) below) any such settlement is effected with the written consent of the Company;</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">against any and all expense whatsoever, as incurred (including the fees and disbursements of counsel chosen by the Representatives), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (i) or (ii) above;</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:7.14323979728499%;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">against any documentary, stamp, registration or similar issuance tax or stock transfer tax, including any interest and penalties, on the sale, issuance or delivery of the Securities by the Company to the Underwriters pursuant to this Agreement;</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;"> however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made in the Registration Statement (or any amendment thereto), including any information deemed to be a part thereof pursuant to Rule 430B, the General Disclosure Package or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with the Underwriter Information.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Indemnification of Company, Directors and Officers</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Each Underwriter severally and not jointly agrees to indemnify and hold harmless the Company, its directors, each of its officers who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act, against any and all loss, liability, claim, damage and expense described in the indemnity contained in subsection (a) of this Section, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendment thereto), including any information deemed to be a part thereof pursuant to Rule 430B, the General Disclosure Package or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with the Underwriter Information.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Actions against Parties; Notification</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  Each indemnified party shall give notice as promptly as reasonably practicable to each indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement.  In the case of parties indemnified pursuant to Section 6(a) above, counsel to the indemnified parties shall be selected by the Representatives, and, in the case of parties indemnified pursuant to Section 6(b) above, counsel to the indemnified parties shall be selected by the Company.  An indemnifying party may participate at its own expense in the defense of any such action; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;"> however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">,</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to the indemnified party.  In no event shall the indemnifying parties be liable for fees and expenses of more than one counsel (in addition to one local counsel in any applicable jurisdiction) separate from their own counsel for all indemnified parties in </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">29</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances.  No indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect of which indemnification or contribution could be sought under this Section 6 or Section 7 hereof (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Settlement without Consent if Failure to Reimburse</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 6(a)(ii) effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;7.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Contribution</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">If the indemnification provided for in Section 6 hereof is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, from the offering of the Securities pursuant to this Agreement or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and of the Underwriters, on the other hand, in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable considerations.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, in connection with the offering of the Securities pursuant to this Agreement shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the Securities pursuant to this Agreement (before deducting expenses) received by the Company, on the one hand, and the total underwriting discount received by the Underwriters, on the other hand, in each case as set forth on the cover of the Prospectus, bear to the aggregate offering price of the Securities as set forth on the cover of the Prospectus.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The relative fault of the Company, on the one hand, and the Underwriters, on the other hand, shall be determined by reference to, among other things, whether any such untrue</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">30</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#x2019; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 7 were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 7.  The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this Section 7 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged omission.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Notwithstanding the provisions of this Section 7, no Underwriter shall be required to contribute any amount in excess of the underwriting commissions received by such Underwriter in connection with the Securities underwritten by it and distributed to purchasers.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">For purposes of this Section 7, each person, if any, who controls an Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act and each Underwriter&#x2019;s Affiliates and selling agents shall have the same rights to contribution as such Underwriter, and each director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as the Company.  The Underwriters&#x2019; respective obligations to contribute pursuant to this Section 7 are several in proportion to the number of Common Stock Securities and Pre-Funded Warrants set forth opposite their respective names in Schedule A hereto and not joint.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;8.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Representations, Warranties and Agreements to Survive</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">All representations, warranties and agreements contained in this Agreement or in certificates of officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless of (i) any investigation made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any Underwriter, its officers or directors, any person controlling the Company and (ii) delivery of and payment for the Securities.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;9.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Termination of Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Termination</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  The Representatives may terminate this Agreement, by notice to the Company, at any time at or prior to the Closing Time (i) if there has been, in the </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">31</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">judgment of the Representatives, since the time of execution of this Agreement or since the respective dates as of which information is given in the Registration Statement, the General Disclosure Package or the Prospectus, any Material Adverse Effect, or (ii) if there has occurred any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Representatives, impracticable or inadvisable to proceed with the completion of the offering or to enforce contracts for the sale of the Securities, or (iii) if trading in any securities of the Company has been suspended or materially limited by the Commission or the Nasdaq Global Select Market, or (iv) if trading generally on the NYSE Amex or the New York Stock Exchange or in the Nasdaq Global Select Market has been suspended or materially limited, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any of said exchanges or by order of the Commission, FINRA or any other governmental authority, or (v) a material disruption has occurred in commercial banking or securities settlement or clearance services in the United States, or (vi) if a banking moratorium has been declared by either Federal or New York authorities.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Liabilities</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  If this Agreement is terminated pursuant to this Section, such termination shall be without liability of any party to any other party except as provided in Section 4 hereof, and </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">provided further </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that Sections 1, 6, 7, 8, 14, 15 and 16 shall survive such termination and remain in full force and effect.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;10.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Default by One or More of the Underwriters</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  </font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">If any Underwriter shall default in its obligation to purchase the Securities that it has agreed to purchase hereunder at the Closing Time, the Representatives may in its discretion arrange for the Representatives or another party or other parties to purchase such Securities on the terms contained herein.  If within thirty six hours after such default by any Underwriter the Representatives do not arrange for the purchase of such Securities, then the Company shall be entitled to a further period of thirty six hours within which to procure another party or other parties satisfactory to the Representatives to purchase such Securities on such terms.  In the event that, within the respective prescribed periods, the Representatives notify the Company that the Representatives have so arranged for the purchase of such Securities, or the Company notifies the Representatives that it has so arranged for the purchase of such Securities, the Representatives or the Company shall have the right to postpone such Closing Time for a period of not more than seven days, in order to effect whatever changes may thereby be made necessary in the Registration Statement or the Prospectus, or in any other documents or arrangements, and the Company agrees to file promptly any amendments or supplements to the Registration Statement or the Prospectus which in the Representatives' opinion may thereby be made necessary.  The term &#34;Underwriter&#34; as used in this Agreement shall include any person substituted under this Section with like effect as if such person had originally been a party to this Agreement with respect to such Securities.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the Representatives and the Company as</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">32</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">provided above, the aggregate number of such Securities which remains unpurchased does not exceed one eleventh of the aggregate number of all the Securities to be purchased at the Closing, then the Company shall have the right to require each non defaulting Underwriter to purchase the number of Securities which such Underwriter agreed to purchase hereunder at the Closing and, in addition, to require each non defaulting Underwriter to purchase its pro rata share (based on the number of Securities which such Underwriter agreed to purchase hereunder) of the Securities of such defaulting Underwriter or Underwriters for which such arrangements have not been made; but nothing herein shall relieve a defaulting Underwriter from liability for its default.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the Representatives and the Company as provided above, the aggregate number of such Securities which remains unpurchased exceeds one eleventh of the aggregate number of all of the Securities to be purchased at the Closing, or if the Company shall not exercise the right described above to require non defaulting Underwriters to purchase Securities of a defaulting Underwriter or Underwriters, then this Agreement shall thereupon terminate, without liability on the part of any non defaulting Underwriter or the Company, except for the expenses to be borne by the Company and the Underwriters as provided in Section 4 hereof and the indemnity and contribution agreements in Sections 6 and 7 hereof; but nothing herein shall relieve a defaulting Underwriter from liability for its default.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;11.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted by any standard form of telecommunication.  Notices to the Underwriters shall be directed to: c/o Cowen and Company, LLC, 599 Lexington Avenue, New York, NY 10022, attention of Head of Equity Capital Markets (facsimile: (646) 562-1249), with a copy to the General Counsel (facsimile: (646) 562-1130), and c/o Stifel, Nicolaus &amp; Company, Incorporated, One South Street, 15th Floor, Baltimore, Maryland 21202 (facsimile: (443) 224-1273), attention of Syndicate Department; notices to the Company shall be directed to it at 919 East Hillsdale Blvd., Suite 250, Foster City, California 94404, attention of Chief Legal Officer (facsimile:  (650) 473-7750), with a copy (which shall not constitute notice) to Cooley LLP, 3 Embarcadero Center, 20th Floor, San Francisco, California 94111, attention of Chadwick L. Mills (facsimile:  (415) 693-2222).</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;12.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">No Advisory or Fiduciary Relationship</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company acknowledges and agrees that (a) the purchase and sale of the Securities pursuant to this Agreement, including the determination of the offering price of the Securities and any related discounts and commissions, is an arm&#x2019;s-length commercial transaction between the Company, on the one hand, and the several Underwriters, on the other hand, and does not constitute a recommendation, investment advice, or solicitation of any action by the Underwriters, (b) in connection with the offering of the Securities and the process leading thereto, each Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company, or its stockholders, creditors, employees or any other party, (c) no Underwriter has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to the offering</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">33</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">of the Securities or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other matters) and no Underwriter has any obligation to the Company with respect to the offering of the Securities except the obligations expressly set forth in this Agreement, (d) the Underwriters and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Company, and (e) the Underwriters have not provided any legal, accounting, regulatory, investment or tax advice with respect to the offering of the Securities and the Company has consulted its own respective legal, accounting, financial, regulatory and tax advisors to the extent it deemed appropriate, and (f) none of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a recommendation, investment advice or solicitation of any action by the Underwriters with respect to any entity or natural person.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;13.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  </font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">This Agreement shall inure to the benefit of and be binding upon the Underwriters, the Company and their respective successors.  Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or corporation, other than the Underwriters, the Company and their respective successors and the controlling persons and officers and directors referred to in Sections 6 and 7 and their heirs and legal representatives, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision herein contained.  This Agreement and all conditions and provisions hereof are intended to be for the sole and exclusive benefit of the Underwriters, the Company and their respective successors, and said controlling persons and officers and directors and their heirs and legal representatives, and for the benefit of no other person, firm or corporation.  No purchaser of Securities from any Underwriter shall be deemed to be a successor by reason merely of such purchase.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;14.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Trial by Jury</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;15.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Recognition of the U.S. Special Resolution Regimes</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">34</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">As used in this Section 15:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">BHC Act Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; has the meaning assigned to the term &#x201c;affiliate&#x201d; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Covered Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; means any of the following:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(a)	a &#x201c;covered entity&#x201d; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(b)	a &#x201c;covered bank&#x201d; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(c)	a &#x201c;covered FSI&#x201d; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Default Right</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">U.S. Special Resolution Regime</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;16.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">GOVERNING LAW</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  </font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">THIS AGREEMENT AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF, THE STATE OF NEW YORK WITHOUT REGARD TO ITS CHOICE OF LAW PROVISIONS.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;17.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Consent to Jurisdiction; Waiver of Immunity</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.  </font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Any legal suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Related Proceedings</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) shall be instituted in (i) the federal courts of the United States of America located in the City and County of New York, Borough of Manhattan or (ii) the courts of the State of New York located in the City and County of New York, Borough of Manhattan (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Specified Courts</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), and each party irrevocably submits to the exclusive jurisdiction (except for proceedings instituted in regard to the enforcement of a judgment of any such court (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Related Judgment</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), as to which such jurisdiction is non-exclusive) of such courts in any such suit, action or proceeding.  Service of any process, summons, notice or document by mail to such party&#x2019;s address set forth above shall be effective service of process for any suit, action or other proceeding brought in any such court.  The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the Specified Courts and irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such suit, action or other proceeding brought in any such court has been brought in an inconvenient forum.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;18.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">TIME</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">35</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">TIME SHALL BE OF THE ESSENCE OF THIS AGREEMENT.  EXCEPT AS OTHERWISE SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;19.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same Agreement. Electronic signatures complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. &#167;&#167; 301-309), as amended from time to time, or other applicable law will be deemed original signatures for purposes of this Agreement.  Transmission by telecopy, electronic mail or other transmission method of an executed counterpart of this Agreement will constitute due and sufficient delivery of such counterpart.</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:6.667%;display:inline-flex;justify-content:flex-start;">Section&nbsp;20.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Effect of Headings</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Section headings herein are for convenience only and shall not affect the construction hereof.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">36</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts, will become a binding agreement between the Underwriters and the Company in accordance with its terms.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Very truly yours,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">GERON CORPORATION</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8%;"></td>
    <td style="width:58.66%;"></td>
    <td style="width:33.34%;"></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-family:Arial;min-width:fit-content;">/s/ John A. Scarlett, M.D.</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Name:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">John A. Scarlett, M.D.</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Title:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">President, Chief Executive Officer and<br>Chairman of the Board</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">CONFIRMED AND ACCEPTED,<br>as of the date first above written:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">COWEN AND COMPANY, LLC</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8%;"></td>
    <td style="width:58.66%;"></td>
    <td style="width:33.34%;"></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-family:Arial;min-width:fit-content;">/s/ Mariel Healy</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Name:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Mariel Healy</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Title:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Managing Director</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Stifel, Nicolaus &amp; Company, Incorporated</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8%;"></td>
    <td style="width:58.66%;"></td>
    <td style="width:33.34%;"></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-family:Arial;min-width:fit-content;">/s/ Seth Rubin</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Name:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Seth Rubin</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Title:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Managing Director</font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">For themselves and as Representatives of the other Underwriters named in Schedule A hereto.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">[</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Signature Page to Underwriting Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:4.533%;display:inline-flex;justify-content:flex-start;">Schedule A</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The offering price per share for the Securities shall be: (i) $3.00 in respect of the shares of Common Stock and (ii) $2.999 in respect of the Pre-Funded Warrants.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The purchase price per share for the Securities to be paid by the several Underwriters shall be: (i) $2.82 in respect of the shares of Common Stock, being an amount equal to the offering price set forth above less $0.18 per share and (ii) $2.819 in respect of the Pre-Funded Warrants, being an amount equal to the offering price set forth above less $0.18 per share underlying the Pre-Funded Warrant, in each case, subject to adjustment in accordance with Section 2(b) for dividends or distributions declared by the Company and payable on the Common Stock Securities and Pre-Funded Warrants.</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.08%;"></td>
    <td style="width:25.96%;"></td>
    <td style="width:25.96%;"></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="padding-bottom:1pt;font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;border-bottom:0.5pt solid;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;min-width:fit-content;">Underwriter</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="padding-bottom:1pt;font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;border-bottom:0.5pt solid;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;min-width:fit-content;">Total Number of<br>Common Stock Securities</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="padding-bottom:1pt;font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;border-bottom:0.5pt solid;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;min-width:fit-content;">Total Number of<br>Pre-Funded Warrants</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Cowen and Company, LLC</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">17,640,000</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">3,361,121</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Stifel, Nicolaus &amp; Company, Incorporated</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">13,020,000</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">2,480,828</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Barclays Capital Inc.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">8,399,999</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">1,600,533</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Wedbush Securities Inc.</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="padding-bottom:1pt;font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;border-bottom:2.25pt double;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">2,939,999</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="padding-bottom:1pt;font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;border-bottom:2.25pt double;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">560,186</font></p></td>
   </tr>
   <tr style="height:11pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;min-width:fit-content;">Total</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="padding-bottom:1pt;font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;border-bottom:2.25pt double;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;min-width:fit-content;">41,999,998</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="padding-bottom:1pt;font-size:11pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:2pt;border-bottom:2.25pt double;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:Arial;min-width:fit-content;">8,002,668</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Sch. A-</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:4.533%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">SCHEDULE B</font></div></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:4.533%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">(a) Pricing Terms</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company is selling 41,999,998 shares of Common Stock.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The Company is selling 8,002,668 Pre-Funded Warrants.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The offering price per share for the Shares shall be: (i) $3.00 in respect of the shares of Common Stock and (ii) $2.999 in respect of the Pre-Funded Warrants.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The estimated net proceeds to the Company after deducting underwriting discounts and commissions are $141.0 million.</font></div></div>
  <div style="font-size:0;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:4.533%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">(b) Free Writing Prospectuses</font></div></div>
  <p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">None.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Sch. B-</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <div style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:4.533%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">SCHEDULE C</font></div></div>
  <div style="font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:4.533%;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">List of Persons and Entities Subject to Lock-up</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">John A. Scarlett, M.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Michelle Robertson</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Faye Feller, M.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Andrew J. Grethlein, Ph.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Anil Kapur</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Scott A. Samuels, Esq.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Gaurav Aggarwal, M.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Dawn C. Bir</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">V. Bryan Lawlis, Ph.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">John F. McDonald</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Susan M. Molineaux, Ph.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Elizabeth G. O&#x2019;Farrell</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Robert J. Spiegel, M.D., FACP</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Sch. C-</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Exhibit A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">FORM OF LOCK-UP AGREEMENT</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">[</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Attached</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Geron Corporation</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Form of Lock-Up Agreement</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">___________________, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Cowen and Company, LLC</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Stifel, Nicolaus &amp; Company, Incorporated</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">As Representatives of the several Underwriters</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">named in Schedule A to the Underwriting Agreement</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">c/o Cowen and Company, LLC</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">599 Lexington Avenue</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">New York, NY 10022</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">c/o Stifel, Nicolaus &amp; Company, Incorporated</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">787 Seventh Avenue</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">New York, New York 10019</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Re:  </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:Arial;min-width:fit-content;">Geron Corporation - Lock-Up Agreement</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Ladies and Gentlemen:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The undersigned, a stockholder and an officer and/or director of Geron Corporation, a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), understands that Cowen and Company, LLC (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">TD Cowen</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) and Stifel, Nicolaus &amp; Company, Incorporated (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Stifel</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) propose to enter into an Underwriting Agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Underwriting Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), on behalf of the several Underwriters named in Schedule A thereto (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Underwriters</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) for whom TD Cowen and Stifel are is acting as representatives, with the Company providing for the public offering of shares (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) of the Company&#x2019;s common stock, par value $0.001 per share (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;). In recognition of the benefit that such an offering will confer upon the undersigned as a stockholder and an officer and/or director of the Company, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with each underwriter to be named in the Underwriting Agreement that, during the period beginning on the date hereof and ending on the date that is 75 days from the date of the Underwriting Agreement (subject to extensions as discussed below, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Lock-Up Period</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), the undersigned will not, without the prior written consent of TD Cowen (or an affiliate thereof) and Stifel, directly or indirectly, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of, or otherwise dispose of or transfer any shares of the Company&#x2019;s Common Stock or any securities convertible into or exchangeable or exercisable for Common Stock, whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Lock-Up Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), or exercise any right with respect to the registration of any of the Lock-up Securities, under the Securities Act of 1933, as amended, or (ii) enter into any</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the Lock-Up Securities, whether any such swap or transaction is to be settled by delivery of Common Stock or other securities, in cash or otherwise; </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">, that the foregoing restrictions shall (1) no longer apply to the undersigned at such time as the undersigned ceases to be an officer and/or director of the Company, </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">that in any such case, any transfers made are not required to be reported with the Securities and Exchange Commission in accordance with Section 16 (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Section 16</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) of the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;), during the Lock-Up Period, and (2) not apply to the exercise of any option, warrant or other right to acquire shares of Common Stock on a cash basis or the conversion of any convertible security into securities of the Company, </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> that in any such case, the Common Stock issued upon such exercise, settlement or conversion shall remain subject to the provisions of this lock-up agreement (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">Lock-Up Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Notwithstanding the foregoing, and subject to the conditions in this paragraph, the undersigned may transfer the Lock-Up Securities without the prior written consent of the representatives,</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> that: (1) the representatives receive a signed lock-up agreement for the balance of the Lock-Up Period from each donee, trustee, distributee, or transferee, as the case may be; (2) any such transfer shall not involve a disposition for value; (3) in the case of clauses (ii) through (iv) below, such transfers are not required to be reported with the Securities and Exchange Commission during the Lock-Up Period; (4) in the case of clauses (iv) and (v) below, if the filing of a report is required in accordance with Section 16 of the Exchange Act during the Lock-Up Period, the undersigned shall include a statement in such report to clearly indicate in the footnotes thereto that the filing relates to the circumstances described in such clauses; and (5) the undersigned does not otherwise voluntarily effect any public filing or report regarding such transfers during the Lock-Up Period:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(i) as a </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">bona fide </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">gift or gifts; or</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(ii) to the immediate family (as defined below) of the undersigned or to any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned; or</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(iii) to any corporation, partnership, limited liability company or other entity all of the beneficial ownership interests of which are held exclusively by the undersigned or the immediate family of the undersigned; or</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(iv) pursuant to a qualified domestic order or in connection with a divorce settlement; or</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">(v) by will, other testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family of the undersigned upon the death of the undersigned.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">As used herein, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">immediate family</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d; shall mean the spouse, domestic partner, lineal descendant, father, mother, brother, sister or any other person with whom the undersigned has a relationship by blood, marriage or adoption not more remote than first cousin.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Notwithstanding the foregoing, and subject to the conditions in this paragraph, the undersigned may also transfer the Lock-Up Securities without the prior written consent of the representatives if any such transfers are made by the undersigned: (i) pursuant to a written trading plan intended to meet the requirements of Rule 10b5-1 under the Exchange Act (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;min-width:fit-content;">10b5-1 Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#x201d;) that is in</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">effect as of the date hereof; (ii) to the Company to satisfy tax withholding obligations of the undersigned upon exercise or vesting of stock options, restricted stock units or other equity awards, or in connection with the &#x201c;net&#x201d; or cashless exercise of stock options, pursuant to the Company&#x2019;s equity compensation plans and arrangements; or (iii) pursuant to the conversion or sale of, or an offer to purchase, all or substantially all of the outstanding Common Stock, whether pursuant to a merger, tender offer or otherwise; </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">, that in the case of any transfer described in clause (i) of this paragraph, it shall be a condition to the transfer that if the undersigned is required to file a report under Section 16 of the Exchange Act, the undersigned shall include a statement in such report to the effect that such transfer is being made pursuant to a previously adopted 10b5-1 Plan; </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided further</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> that in the case of any transfer described in clause (ii) of this paragraph, it shall be a condition to the transfer that if the undersigned is required to file a report under Section 16 of the Exchange Act, the undersigned shall include a statement in such report to the effect that such transfer is being made for tax withholding obligations; and </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided further</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> that in the case of any conversion or sale described in clause (iii) of this paragraph, in the event that such transaction is abandoned, the Lock-Up Securities shall remain subject to the restrictions hereunder.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Furthermore, the undersigned may sell shares of Common Stock of the Company purchased by the undersigned on the open market following the public offering of the Shares if and only if (i) such sales are not required to be reported with the Securities Exchange Commission during the Lock-Up Period, or otherwise and (ii) the undersigned does not otherwise voluntarily effect any public filing or report regarding such sales during the Lock-Up Period.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">In addition, notwithstanding the foregoing, and subject to the conditions and provisos in this paragraph, the undersigned may also establish a new 10b5-1 Plan or amend an existing 10b5-1 Plan, provided that (i) no direct or indirect offers, pledges, sales, contracts to sell, sales of any option or contract to purchase, purchases of any option or contract to sell, grants of any option, right or warrant to purchase, or other disposals or transfers of any Lock-Up Securities may be effected pursuant to such 10b5-1 Plan during the Lock-Up Period and (ii) no public disclosure of the entry into or amendment of such 10b5-1 Plan shall be made by any person until after the expiration of the Lock-Up Period (other than as required under Item 408 and Item 601 of Regulation S-K).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The undersigned now has, and, except as contemplated above, for the duration of this Lock-Up Agreement will have, good and marketable title to the undersigned&#x2019;s shares of Common Stock, free and clear of all liens, encumbrances, and claims whatsoever.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&#x2019;s transfer agent and registrar against the transfer of the Lock-Up Securities except in compliance with the foregoing restrictions.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">The undersigned acknowledges and agrees that none of the Underwriters has made any recommendation or provided any investment or other advice to the undersigned with respect to this Lock-Up Agreement or the subject matter hereof, and the undersigned has consulted its own legal, accounting, financial, regulatory, tax and other advisors with respect to this Lock-Up Agreement and the subject matter hereof to the extent the undersigned has deemed appropriate.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">This Lock-Up Agreement shall be governed by and construed in accordance with the laws of the State of New York.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">It is understood that, if (1) the Company notifies the representatives that it does not intend to proceed with the public offering of the Shares, (2) the Underwriting Agreement does not become effective, (3) the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated for any reason prior to payment for and delivery of the Shares, or (4) the Underwriting Agreement for the public offering the Shares shall not have been executed by April 30, 2024, then this Lock-Up Agreement shall immediately be terminated and the undersigned shall automatically be released from all of his or her or obligations under this Lock-Up Agreement.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">[Signature page follows]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">              Very truly yours,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">________________________________________</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">                                                                         Exact Name of Stockholder</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">________________________________________</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">                                                                         Authorized Signature</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">________________________________________</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">                                                                         Title</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">Exhibit B</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">FORM OF PRE-FUNDED WARRANT</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">[</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Attached</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">]</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PRE-FUNDED COMMON STOCK PURCHASE WARRANT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">GERON CORPORATION</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Shares:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date of Issuance:                           , 2024 (such date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Issue Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;)<br>Warrant No.: PF-[     ]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">THIS COMMON STOCK PURCHASE WARRANT (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) certifies that, for value received, the registered holder hereof or its permitted assigns (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is entitled, upon the terms and subject to the limitations on exercise and the conditions set forth herein, at any time on or after the Issue Date, to subscribe for and purchase from </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Geron Corporation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), up to                          shares (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of the Company&#x2019;s common stock, par value $0.001 per share (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of the Pre-Funded Common Stock Purchase Warrants issued in connection with the transactions contemplated by (i) that certain Underwriting Agreement, dated as of                          , 2024, by and between the Company and Cowen and Company, LLC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and Stifel, Nicolaus &amp; Company, Incorporated, as the representatives of the several underwriters named therein, (ii) the Company&#x2019;s Registration Statement on Form S-3 (File No. 333-269111) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and (iii) the Company&#x2019;s prospectus supplement dated                          , 2024 to the base prospectus (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prospectus Supplement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) contained in the Registration Statement dated January 4, 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 1</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  For purposes of this Warrant, the following terms shall have the following meanings:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act of 1933, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1933 Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">b) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attribution Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder funds or managed accounts, currently, or from time to time after the Issue Date, directly or indirectly managed or advised by the Holder&#x2019;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the foregoing and (iv) any other Persons whose beneficial ownership of Common Stock would or could be aggregated with the Holder&#x2019;s and the other Attribution Parties for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1934 Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). For clarity, the purpose of the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage (as defined in Section 2(e)).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">c) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Bloomberg</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means Bloomberg Financial Markets.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Business Day</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any day except any Saturday, any Sunday, any day that is a federal legal holiday in the United States or any day on which the New York Stock Exchange is authorized or required by law or other governmental action to close.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">e) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Group</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means a &#x201c;group&#x201d; as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">f) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">g) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Trading Day</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any day on which the Common Stock is traded on the Trading Market.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">h) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Trading Market</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the principal securities exchange or securities market, including an over-the-counter market, on which the Common Stock is then traded in the United States.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted Average Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, for any security as of any date, the dollar volume-weighted average price for such security on the Trading Market during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg through its &#x201c;Volume at Price&#x201d; function or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in the &#x201c;pink sheets&#x201d;  published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices). If the Weighted Average Price cannot be calculated for such security on such date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved pursuant to Section 5(n) with the term &#x201c;Weighted Average Price&#x201d; being substituted for the term &#x201c;Exercise Price.&#x201d; All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to the terms and conditions hereof, the purchase rights represented by this Warrant may be exercised, in whole or in part, at any time or times on or after the Issue Date by delivery (whether via facsimile or otherwise) to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed copy of the Notice of Exercise form annexed hereto (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notice of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and by payment to the Company of an amount equal to the aggregate Exercise Price of the Warrant Shares thereby purchased by wire transfer (or by notifying the Company that this Warrant is being exercised pursuant to a Cashless Exercise (as defined below)). No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. The Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days after the date the Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment as provided herein (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Mechanics of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Delivery of Warrant Shares Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Certificates for shares purchased hereunder shall be transmitted to the Holder by crediting the account of the Holder&#x2019;s prime broker with The Depository Trust Company (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">DTC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) through its Deposit/Withdrawal at Custodian (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">DWAC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) system if the Company is then a participant in such system and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise by the date that is two (2) Trading Days after the receipt by the Company of the Notice of Exercise (provided that payment of the Exercise Price (or notification of Cashless Exercise, if applicable) has then been received by the Company) (such date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Share Delivery Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). This Warrant shall be deemed to have been exercised upon proper delivery of the Notice of Exercise and payment of the Exercise Price (or notification of Cashless Exercise). The</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Shares shall be deemed to have been issued, and the Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised.  The Company shall use commercially reasonable efforts to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ii. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Delivery of New Warrant Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the certificate or certificates representing Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">iii. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(c)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date  (other than a failure caused by incorrect or incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#x2019;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Buy-In</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), then the Company shall either (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#x2019;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, or (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of this Warrant with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. In connection with the foregoing, the Holder shall (i) use its reasonable efforts to notify the Company in advance of any pending exercise of this Warrant in order to enable to the Company to deliver the Warrant Shares by the Warrant Share Delivery Date and (ii) provide the Company written notice within three (3) Business Days after the occurrence of a Buy-In, indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.  Subject to Section 5(i), nothing herein shall limit a Holder&#x2019;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#x2019;s failure to timely deliver Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">iv.  No Fractional Shares or Scrip</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round (up or down) to the nearest whole share.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">v. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Charges, Taxes and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">vi. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Closing of Books</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant pursuant to the terms hereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cashless Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Notwithstanding anything contained herein to the contrary, the Holder may exercise this Warrant, whether in whole or in part, and in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Exercise Price, by effecting a cashless exercise of this Warrant pursuant to which the Holder shall receive upon such cashless exercise the &#x201c;Net Number&#x201d; of Warrant Shares determined according to the following formula (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cashless Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;):</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net Number =	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">   (A x B) - (A x C)   </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><br>			B</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For purposes of the foregoing formula:</font></p>
  <p style="margin-left:6.667%;text-indent:-7.843%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A =	the total number of shares of Common Stock with respect to which this Warrant is then being exercised.</font></p>
  <p style="margin-left:6.667%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B =	the Weighted Average Price of the shares of Common Stock on the date immediately preceding the date of the Notice of Exercise.</font></p>
  <p style="margin-left:6.667%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">C =	the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If Warrant Shares are issued in such a Cashless Exercise, the Company acknowledges and agrees that in accordance with Section 3(a)(9) of the 1933 Act, the Warrant Shares shall take on the registered characteristics of the Warrant being exercised, and the holding period of the Warrant being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to take any position contrary to this Section 2(d).</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Holder&#x2019;s Exercise Limitations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  Notwithstanding anything to the contrary contained herein, the Company shall not effect the exercise of any portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, pursuant to the terms and conditions of this Warrant and any such exercise shall be null and void and treated as if never made, to the extent that immediately prior to or after giving effect to such exercise, the Holder together with the other Attribution Parties collectively would beneficially own in excess of 9.99% (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Maximum Percentage</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder and the other Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (A) exercise of the remaining, unexercised portion of this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible notes or convertible preferred stock or warrants, including the other Warrants) beneficially owned by the Holder or any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 2(e). For purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the 1934 Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder. For purposes of this Warrant, in determining the number of outstanding shares of Common Stock the Holder may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company&#x2019;s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q and Current Reports on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (y) a more recent public announcement by the Company or (z) any other written notice by the Company setting forth the number of</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shares of Common Stock outstanding (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reported Outstanding Share Number</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). If the Company receives a Notice of Exercise from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall (i) notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the Holder&#x2019;s beneficial ownership, as determined pursuant to this Section 2(e), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be purchased pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reduction Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and (ii) as soon as reasonably practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction Shares. For any reason at any time, upon the written request of the Holder, the Company shall within five (5) Business Days confirm orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and any other Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of Common Stock to the Holder upon exercise of this Warrant results in the Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which the Holder&#x2019;s and the other Attribution Parties&#x2019; aggregate beneficial ownership exceeds the Maximum Percentage (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Excess Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the Holder the exercise price paid by the Holder for the Excess Shares. Upon delivery of a written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage (not in excess of 19.99% of the issued and outstanding shares of Common Stock immediately after giving effect to the issuance of the shares of Common Stock issuable upon exercise of this Warrant if exceeding that limit would result in a change of control under Nasdaq Listing Rule 5635(b) or any successor rule) as specified in such notice; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice is delivered to the Company and (ii) any such increase or decrease will apply only to the Holder and the other Attribution Parties and not to any other holder of Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to the extent necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 2(e) or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of this Warrant.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 3</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Subdivision or Combination of Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. During such time as this Warrant is outstanding, if the Company  subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately increased. If the Company at any time on or after the Subscription Date combines (by combination, reverse stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any adjustment under this Section 3(a) shall become effective at the close of business on the date the subdivision or combination becomes effective.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Subsequent Rights Offerings</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  In addition to any adjustments pursuant to Section 3(a) above, if during such time as this Warrant is outstanding the Company grants, issues or sells any rights to purchase stock, warrants, securities or other property, in each case pro rata to the record holders of any class of shares of Common Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Purchase Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, Section 2(e) hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, to the extent that the Holder&#x2019;s right to participate in any such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pro Rata Distributions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to all holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, Section 2(e) hereof) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, to the extent that the Holder's right to participate in any such Distribution would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fundamental Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions (which, for the avoidance of doubt, shall not include a license or other agreement granting rights to intellectual property), (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding shares of Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fundamental Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (together, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Alternate Consideration</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), if any, receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Any such payment of such amount of such Alternative Consideration shall be made in the same form of consideration (whether securities, cash or property) as is given to the holders of Common Stock in such Fundamental Transaction, and if multiple forms of consideration are given, the consideration shall be paid to the Holder in the same proportion as such consideration is paid to the holders of Common Stock. The terms of any agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this Section 3(d) and insuring that this Warrant (or any such replacement security) will be similarly adjusted upon any subsequent Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Successor Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for the Company (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#x201c;Company&#x201d; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.  Notwithstanding the foregoing, and without limiting Section 2(e) hereof, the Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section 3(d) to permit a Fundamental Transaction without the assumption of this Warrant.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Calculations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. All calculations under this Section 3 shall be made to the nearest cent or the nearest whole share, as the case may be. For purposes of this Section 3, any calculation of the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall not include treasury shares, if any. Notwithstanding anything to the contrary in this Section 3, no adjustment in the Exercise Price shall be required unless such adjustment would require an increase or decrease of at least 1% in such price; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, that any adjustments which by reason of the immediately preceding sentence are not required to be made shall be carried forward and taken into account in any subsequent adjustment. In any case in which this Section 3 shall require that an adjustment in the Exercise Price be made effective as of a record date for a specified event, if Holder exercises this Warrant after such record date, the Company may elect to defer, until the occurrence of such event, the issuance of the shares of Common Stock and other capital stock of the Company in excess of the shares of Common Stock and other capital stock of the Company, if any, issuable upon such exercise on the basis of the Exercise Price in effect prior to such adjustment; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, that in such case the Company shall deliver to the Holder a due bill or other appropriate instrument evidencing the Holder&#x2019;s right to receive such additional shares and/or other capital securities upon the occurrence of the event requiring such adjustment.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Par Value</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Notwithstanding anything to the contrary in this Warrant, in no event shall the Exercise Price be reduced below the par value of the Company&#x2019;s Common Stock.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Transfer of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Transferability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder  are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company (or other designated agent), together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">New Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company (or other designated agent), together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date set forth on the first page of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Register</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall initially serve as warrant agent under this Warrant. The Company shall register ownership of this Warrant, upon records to be maintained by the Company for that purpose (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Register</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any assignee to which this Warrant is assigned hereunder) from time to time. Upon thirty (30) days&#x2019; notice to the Holder, the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder&#x2019;s last address as shown on the Warrant Register.  The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 5</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Miscellaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No Rights as Stockholder Until Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Loss, Theft, Destruction or Mutilation of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to them of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Saturdays, Sundays, Holidays, etc</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Authorized Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant (without regard to any limitations on exercise contained herein). The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">8</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">necessary certificates for the Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue). Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, in each case to avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Governing Law</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. This Warrant shall be governed by, and construed in accordance with, the laws of the State of New York without giving effect to the conflicts of law principles thereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">f) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonwaiver and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. No course of dealing or any delay or failure to exercise any right hereunder on the part of the Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#x2019;s rights, powers or remedies. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#x2019; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">g) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notice Procedures</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via email or facsimile at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via email or facsimile on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or by International Federal Express, (d) the third (3rd) Trading Day following the date of mailing if sent by first-class registered or certified mail domestic, or (e) upon actual receipt by the party to whom such notice is required to be given. The addresses for such communications shall be:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If to the Company:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Geron Corporation</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">919 E. Hillsdale Blvd., Suite 250</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Foster City, California 94404</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fax:  (650) 473-7700</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attention: Pamela Smith</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Email: psmith@geron.com</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">With copy to:</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">9</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cooley LLP</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3 Embarcadero Center, 20</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Floor</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">San Francisco, CA 94111</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fax:  (415) 693-2222</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attention:  Chadwick L. Mills, Esq.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Email:  cmills@cooley.com</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If to the Holder:</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To the address, email address or facsimile number set forth in the Warrant Register, or as otherwise provided by the Holder to the Company in accordance with this Section 5(g)(i).</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ii. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adjustment to Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Whenever the Exercise Price or number of Warrant Shares is adjusted pursuant to any provision of Section 3, the Company shall promptly provide the Holder a notice setting forth the Exercise Price and number of Warrant Shares after such adjustment and setting forth a brief statement of the facts requiring such adjustment.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">iii. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notice to Allow Exercise by the Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. After the Issue Date if (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company (which, for the avoidance of doubt, shall not include a license or other agreement granting rights to intellectual property), or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register, at least ten (10) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">h) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Limitation of Liability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate. Notwithstanding the foregoing or anything else herein to the contrary, if the Company is for any reason unable to issue and deliver Warrant Shares upon exercise of this Warrant as required pursuant to the terms hereof, the Company shall have no obligation to pay to the Holder any cash or other consideration or otherwise &#x201c;net cash settle&#x201d; this Warrant.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">10</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">j) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Successors and Assigns</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">k) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">l) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">m) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Confidentiality</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Holder agrees to keep confidential any proprietary information relating to the Company delivered by the Company hereunder; provided that nothing herein shall prevent the Holder from disclosing such information: (i) to any holder of Warrants or Warrant Shares, (ii) to any Affiliate of any holder of Warrants or Warrant Shares or any actual or potential transferee of the rights or obligations hereunder that agrees to be bound by this Section 5(m), (iii) upon order, subpoena, or other process of any court or administrative agency or otherwise required by law, (iv) upon the request or demand of any regulatory agency or authority having jurisdiction over such party, (v) which has been publicly disclosed without breach of any obligation to the Company, (vi) which has been obtained from any Person that is not a party hereto or an Affiliate of any such party without any breach of any obligation to the Company, (vii) in connection with the exercise of any remedy, or the resolution of any dispute hereunder, (viii) to the legal counsel or certified public accountants for any holder of Warrants or Warrant Shares, or (ix) as otherwise expressly contemplated by this Warrant. Notwithstanding the foregoing, the Company shall not provide material, non-public information or confidential or proprietary information to the Holder without such Holder&#x2019;s written consent.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">n) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dispute Resolution</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile within two (2) Business Days of receipt of the Notice of Exercise giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2) Business Days submit via facsimile (i) the disputed determination of the Exercise Price to an independent, reputable investment bank selected by the Company and approved by the Holder or (ii) the disputed arithmetic calculation of the Warrant Shares to the Company&#x2019;s independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than ten (10) Business Days from the time it receives the disputed determinations or calculations. Such investment bank&#x2019;s or accountant&#x2019;s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error. The expenses of the investment bank and accountant will be borne by the Company unless the investment bank or accountant determines that the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares by the Holder was incorrect, in which case the expenses of the investment bank and accountant will be borne by the Holder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">o) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Headings</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">********************</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Signature Pages Follow)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">11</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:12%;"></td>
    <td style="width:2.5%;"></td>
    <td style="width:85.5%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">GERON CORPORATION</font></p></td>
   </tr>
   <tr style="height:18pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">12</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTICE OF EXERCISE</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TO: GERON CORPORATION</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(1) The undersigned holder of Warrant No. PF-</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">                </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> hereby elects to purchase                               Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(2) Payment shall take the form of (check applicable box):</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf0a8;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash Exercise:  lawful money of the United States; or</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf0a8;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cashless Exercise: the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in Section 2(d), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in Section 2(d).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:3%;"></td>
    <td style="width:4%;"></td>
    <td style="width:93%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(4) By its delivery of this Notice of Exercise, the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced hereby the Holder will not beneficially own in excess of the number of shares of Common Stock (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended) permitted to be owned under Section 2(e) of the Warrant to which this notice relates.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:3%;"></td>
    <td style="width:4%;"></td>
    <td style="width:93%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">[SIGNATURE OF HOLDER]</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:19%;"></td>
    <td style="width:1%;"></td>
    <td style="width:80%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name of Investing Entity:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:40%;"></td>
    <td style="width:1%;"></td>
    <td style="width:59%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Investing Entity:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:23%;"></td>
    <td style="width:1%;"></td>
    <td style="width:76%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name of Authorized Signatory:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:22%;"></td>
    <td style="width:1%;"></td>
    <td style="width:77%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title of Authorized Signatory:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4%;"></td>
    <td style="width:1%;"></td>
    <td style="width:95%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">13</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4%;"></td>
    <td style="width:1%;"></td>
    <td style="width:95%;"></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASSIGNMENT FORM</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(To assign the foregoing warrant, execute</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">this form and supply required information.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Do not use this form to exercise the warrant.)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FOR VALUE RECEIVED, [         ] all of or [           ] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:74.175%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:10.822%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:11.002%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">whose address is</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">.</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50%;"></td>
    <td style="width:1%;"></td>
    <td style="width:49%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Dated: ,</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:26.985%;"></td>
    <td style="width:1%;"></td>
    <td style="width:14.003%;"></td>
    <td style="width:1%;"></td>
    <td style="width:28.006%;"></td>
    <td style="width:1%;"></td>
    <td style="width:28.006%;"></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Holder&#x2019;s Signature:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Holder&#x2019;s Address:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">15</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>gern-ex4_1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<html>
 <head>
  <title>EX-4.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 4.1</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PRE-FUNDED COMMON STOCK PURCHASE WARRANT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">GERON CORPORATION</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Shares:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date of Issuance:                           , 2024 (such date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Issue Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;)<br>Warrant No.: PF-[     ]</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">THIS COMMON STOCK PURCHASE WARRANT (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) certifies that, for value received, the registered holder hereof or its permitted assigns (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) is entitled, upon the terms and subject to the limitations on exercise and the conditions set forth herein, at any time on or after the Issue Date, to subscribe for and purchase from </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Geron Corporation</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), up to                          shares (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of the Company&#x2019;s common stock, par value $0.001 per share (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of the Pre-Funded Common Stock Purchase Warrants issued in connection with the transactions contemplated by (i) that certain Underwriting Agreement, dated as of                          , 2024, by and between the Company and Cowen and Company, LLC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and Stifel, Nicolaus &amp; Company, Incorporated, as the representatives of the several underwriters named therein, (ii) the Company&#x2019;s Registration Statement on Form S-3 (File No. 333-269111) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and (iii) the Company&#x2019;s prospectus supplement dated                          , 2024 to the base prospectus (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prospectus Supplement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) contained in the Registration Statement dated January 4, 2023.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 1</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  For purposes of this Warrant, the following terms shall have the following meanings:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act of 1933, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1933 Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">b) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attribution Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder funds or managed accounts, currently, or from time to time after the Issue Date, directly or indirectly managed or advised by the Holder&#x2019;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the foregoing and (iv) any other Persons whose beneficial ownership of Common Stock would or could be aggregated with the Holder&#x2019;s and the other Attribution Parties for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1934 Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). For clarity, the purpose of the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage (as defined in Section 2(e)).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">c) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Bloomberg</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means Bloomberg Financial Markets.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Business Day</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any day except any Saturday, any Sunday, any day that is a federal legal holiday in the United States or any day on which the New York Stock Exchange is authorized or required by law or other governmental action to close.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">e) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Group</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means a &#x201c;group&#x201d; as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">f) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">g) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Trading Day</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means any day on which the Common Stock is traded on the Trading Market.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">h) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Trading Market</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means the principal securities exchange or securities market, including an over-the-counter market, on which the Common Stock is then traded in the United States.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i) &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted Average Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d; means, for any security as of any date, the dollar volume-weighted average price for such security on the Trading Market during the period beginning at 9:30:01 a.m., New York City time, and ending at</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4:00:00 p.m., New York City time, as reported by Bloomberg through its &#x201c;Volume at Price&#x201d; function or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in the &#x201c;pink sheets&#x201d;  published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices). If the Weighted Average Price cannot be calculated for such security on such date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved pursuant to Section 5(n) with the term &#x201c;Weighted Average Price&#x201d; being substituted for the term &#x201c;Exercise Price.&#x201d; All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to the terms and conditions hereof, the purchase rights represented by this Warrant may be exercised, in whole or in part, at any time or times on or after the Issue Date by delivery (whether via facsimile or otherwise) to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed copy of the Notice of Exercise form annexed hereto (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notice of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and by payment to the Company of an amount equal to the aggregate Exercise Price of the Warrant Shares thereby purchased by wire transfer (or by notifying the Company that this Warrant is being exercised pursuant to a Cashless Exercise (as defined below)). No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. The Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days after the date the Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment as provided herein (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Mechanics of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Delivery of Warrant Shares Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Certificates for shares purchased hereunder shall be transmitted to the Holder by crediting the account of the Holder&#x2019;s prime broker with The Depository Trust Company (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">DTC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) through its Deposit/Withdrawal at Custodian (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">DWAC</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) system if the Company is then a participant in such system and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise by the date that is two (2) Trading Days after the receipt by the Company of the Notice of Exercise (provided that payment of the Exercise Price (or notification of Cashless Exercise, if applicable) has then been received by the Company) (such date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Share Delivery Date</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). This Warrant shall be deemed to have been exercised upon proper delivery of the Notice of Exercise and payment of the Exercise Price (or notification of Cashless Exercise). The Warrant Shares shall be deemed to have been issued, and the Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised.  The Company shall use commercially reasonable efforts to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ii. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Delivery of New Warrant Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the certificate or</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">certificates representing Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">iii. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(c)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date  (other than a failure caused by incorrect or incomplete information provided by the Holder to the Company), and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#x2019;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Buy-In</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), then the Company shall either (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#x2019;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, or (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of this Warrant with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. In connection with the foregoing, the Holder shall (i) use its reasonable efforts to notify the Company in advance of any pending exercise of this Warrant in order to enable to the Company to deliver the Warrant Shares by the Warrant Share Delivery Date and (ii) provide the Company written notice within three (3) Business Days after the occurrence of a Buy-In, indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.  Subject to Section 5(i), nothing herein shall limit a Holder&#x2019;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#x2019;s failure to timely deliver Warrant Shares upon exercise of the Warrant as required pursuant to the terms hereof.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">iv.  No Fractional Shares or Scrip</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round (up or down) to the nearest whole share.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">v. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Charges, Taxes and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">vi. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Closing of Books</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant pursuant to the terms hereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cashless Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Notwithstanding anything contained herein to the contrary, the Holder may exercise this Warrant, whether in whole or in part, and in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Exercise Price, by effecting a cashless exercise of this Warrant pursuant to which the Holder shall receive upon such cashless exercise the &#x201c;Net Number&#x201d; of Warrant Shares determined according to the following formula (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cashless Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;):</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net Number =	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">   (A x B) - (A x C)   </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><br>			B</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For purposes of the foregoing formula:</font></p>
  <p style="margin-left:6.667%;text-indent:-7.843%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:8.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A =	the total number of shares of Common Stock with respect to which this Warrant is then being exercised.</font></p>
  <p style="margin-left:6.667%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B =	the Weighted Average Price of the shares of Common Stock on the date immediately preceding the date of the Notice of Exercise.</font></p>
  <p style="margin-left:6.667%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">C =	the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If Warrant Shares are issued in such a Cashless Exercise, the Company acknowledges and agrees that in accordance with Section 3(a)(9) of the 1933 Act, the Warrant Shares shall take on the registered characteristics of the Warrant being exercised, and the holding period of the Warrant being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to take any position contrary to this Section 2(d).</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Holder&#x2019;s Exercise Limitations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  Notwithstanding anything to the contrary contained herein, the Company shall not effect the exercise of any portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, pursuant to the terms and conditions of this Warrant and any such exercise shall be null and void and treated as if never made, to the extent that immediately prior to or after giving effect to such exercise, the Holder together with the other Attribution Parties collectively would beneficially own in excess of 9.99% (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Maximum Percentage</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) of the number of shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder and the other Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (A) exercise of the remaining, unexercised portion of this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible notes or convertible preferred stock or warrants, including the other Warrants) beneficially owned by the Holder or any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section 2(e). For purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the 1934 Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder. For purposes of this Warrant, in determining the number of outstanding shares of Common Stock the Holder may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company&#x2019;s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q and Current Reports on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (y) a more recent public announcement by the Company or (z) any other written notice by the Company setting forth the number of shares of Common Stock outstanding (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reported Outstanding Share Number</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;). If the Company receives a Notice of Exercise from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall (i) notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the Holder&#x2019;s beneficial ownership, as determined pursuant to this Section 2(e), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be purchased pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reduction Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) and (ii) as soon as</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reasonably practicable, the Company shall return to the Holder any exercise price paid by the Holder for the Reduction Shares. For any reason at any time, upon the written request of the Holder, the Company shall within five (5) Business Days confirm orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and any other Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of Common Stock to the Holder upon exercise of this Warrant results in the Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which the Holder&#x2019;s and the other Attribution Parties&#x2019; aggregate beneficial ownership exceeds the Maximum Percentage (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Excess Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the Holder the exercise price paid by the Holder for the Excess Shares. Upon delivery of a written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage (not in excess of 19.99% of the issued and outstanding shares of Common Stock immediately after giving effect to the issuance of the shares of Common Stock issuable upon exercise of this Warrant if exceeding that limit would result in a change of control under Nasdaq Listing Rule 5635(b) or any successor rule) as specified in such notice; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice is delivered to the Company and (ii) any such increase or decrease will apply only to the Holder and the other Attribution Parties and not to any other holder of Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to the extent necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 2(e) or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of this Warrant.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 3</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Subdivision or Combination of Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. During such time as this Warrant is outstanding, if the Company  subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately increased. If the Company at any time on or after the Subscription Date combines (by combination, reverse stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any adjustment under this Section 3(a) shall become effective at the close of business on the date the subdivision or combination becomes effective.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Subsequent Rights Offerings</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  In addition to any adjustments pursuant to Section 3(a) above, if during such time as this Warrant is outstanding the Company grants, issues or sells any rights to purchase stock, warrants, securities or other property, in each case pro rata to the record holders of any class of shares of Common Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Purchase Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, Section 2(e) hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, to the extent that the Holder&#x2019;s right to participate in any such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pro Rata Distributions</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to all holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, Section 2(e) hereof) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, to the extent that the Holder's right to participate in any such Distribution would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fundamental Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions (which, for the avoidance of doubt, shall not include a license or other agreement granting rights to intellectual property), (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding shares of Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fundamental Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (together, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Alternate Consideration</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), if any, receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Any such payment of such amount of such Alternative Consideration shall be made in the same form of consideration (whether securities, cash or property) as is given to the holders of Common Stock in such Fundamental Transaction, and if multiple forms of consideration are given, the consideration shall be paid to the Holder in the same proportion as such consideration is paid to the holders of Common Stock. The terms of any</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this Section 3(d) and insuring that this Warrant (or any such replacement security) will be similarly adjusted upon any subsequent Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Successor Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for the Company (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#x201c;Company&#x201d; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.  Notwithstanding the foregoing, and without limiting Section 2(e) hereof, the Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section 3(d) to permit a Fundamental Transaction without the assumption of this Warrant.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Calculations</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. All calculations under this Section 3 shall be made to the nearest cent or the nearest whole share, as the case may be. For purposes of this Section 3, any calculation of the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall not include treasury shares, if any. Notwithstanding anything to the contrary in this Section 3, no adjustment in the Exercise Price shall be required unless such adjustment would require an increase or decrease of at least 1% in such price; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, that any adjustments which by reason of the immediately preceding sentence are not required to be made shall be carried forward and taken into account in any subsequent adjustment. In any case in which this Section 3 shall require that an adjustment in the Exercise Price be made effective as of a record date for a specified event, if Holder exercises this Warrant after such record date, the Company may elect to defer, until the occurrence of such event, the issuance of the shares of Common Stock and other capital stock of the Company in excess of the shares of Common Stock and other capital stock of the Company, if any, issuable upon such exercise on the basis of the Exercise Price in effect prior to such adjustment; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, that in such case the Company shall deliver to the Holder a due bill or other appropriate instrument evidencing the Holder&#x2019;s right to receive such additional shares and/or other capital securities upon the occurrence of the event requiring such adjustment.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Par Value</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Notwithstanding anything to the contrary in this Warrant, in no event shall the Exercise Price be reduced below the par value of the Company&#x2019;s Common Stock.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Transfer of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Transferability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder  are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company (or other designated agent), together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">New Warrants</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company (or other designated agent), together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date set forth on the first page of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Register</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company shall initially serve as warrant agent under this Warrant. The Company shall register ownership of this Warrant, upon records to be maintained by the Company for that purpose (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant Register</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x201d;), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any assignee to which this Warrant is assigned hereunder) from time to time. Upon thirty (30) days&#x2019; notice to the Holder, the Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder&#x2019;s last address as shown on the Warrant Register.  The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 5</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Miscellaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No Rights as Stockholder Until Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">b) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Loss, Theft, Destruction or Mutilation of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to them of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">c) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Saturdays, Sundays, Holidays, etc</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">d) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Authorized Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant (without regard to any limitations on exercise contained herein). The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue). Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, in each case to avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">e) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Governing Law</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. This Warrant shall be governed by, and construed in accordance with, the laws of the State of New York without giving effect to the conflicts of law principles thereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">f) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonwaiver and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. No course of dealing or any delay or failure to exercise any right hereunder on the part of the Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#x2019;s rights, powers or remedies. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#x2019; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">g) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notice Procedures</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.  Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via email or facsimile at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via email or facsimile on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or by International Federal Express, (d) the third (3rd) Trading Day following the date of mailing if sent by first-class registered or certified mail domestic, or (e) upon actual receipt by the party to whom such notice is required to be given. The addresses for such communications shall be:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If to the Company:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Geron Corporation</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">919 E. Hillsdale Blvd., Suite 250</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Foster City, California 94404</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fax:  (650) 473-7700</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attention: Pamela Smith</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Email: psmith@geron.com</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">With copy to:</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cooley LLP</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3 Embarcadero Center, 20</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> Floor</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">San Francisco, CA 94111</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fax:  (415) 693-2222</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attention:  Chadwick L. Mills, Esq.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Email:  cmills@cooley.com</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If to the Holder:</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To the address, email address or facsimile number set forth in the Warrant Register, or as otherwise provided by the Holder to the Company in accordance with this Section 5(g)(i).</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ii. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adjustment to Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Whenever the Exercise Price or number of Warrant Shares is adjusted pursuant to any provision of Section 3, the Company shall promptly provide the Holder a notice setting forth the Exercise Price and number of Warrant Shares after such adjustment and setting forth a brief statement of the facts requiring such adjustment.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">iii. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notice to Allow Exercise by the Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. After the Issue Date if (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company (which, for the avoidance of doubt, shall not include a license or other agreement granting rights to intellectual property), or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register, at least ten (10) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">h) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Limitation of Liability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate. Notwithstanding the foregoing or anything else herein to the contrary, if the Company is for any reason unable to issue and deliver Warrant Shares upon exercise of this Warrant as required pursuant to the terms hereof, the Company shall have no obligation to pay to the Holder any cash or other consideration or otherwise &#x201c;net cash settle&#x201d; this Warrant.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">j) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Successors and Assigns</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">k) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">l) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">m) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Confidentiality</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Holder agrees to keep confidential any proprietary information relating to the Company delivered by the Company hereunder; provided that nothing herein shall prevent the Holder from disclosing such information: (i) to any holder of Warrants or Warrant Shares, (ii) to any Affiliate of any holder of Warrants or Warrant Shares or any actual or potential transferee of the rights or obligations hereunder that agrees to be bound by this Section 5(m), (iii) upon order, subpoena, or other process of any court or administrative agency or otherwise required by law, (iv) upon the request or demand of any regulatory agency or authority having jurisdiction over such party, (v) which has been publicly disclosed without breach of any obligation to the Company, (vi) which has been obtained from any Person that is not a party hereto or an Affiliate of any such party without any breach of any obligation to the Company, (vii) in connection with the exercise of any remedy, or the resolution of any dispute hereunder, (viii) to the legal counsel or certified public accountants for any holder of Warrants or Warrant Shares, or (ix) as otherwise expressly contemplated by this Warrant. Notwithstanding the foregoing, the Company shall not provide material, non-public information or confidential or proprietary information to the Holder without such Holder&#x2019;s written consent.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">n) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dispute Resolution</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile within two (2) Business Days of receipt of the Notice of Exercise giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2) Business Days submit via facsimile (i) the disputed determination of the Exercise Price to an independent, reputable investment bank selected by the Company and approved by the Holder or (ii) the disputed arithmetic calculation of the Warrant Shares to the Company&#x2019;s independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than ten (10) Business Days from the time it receives the disputed determinations or calculations. Such investment bank&#x2019;s or accountant&#x2019;s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error. The expenses of the investment bank and accountant will be borne by the Company unless the investment bank or accountant determines that the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares by the Holder was incorrect, in which case the expenses of the investment bank and accountant will be borne by the Holder.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">o) </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Headings</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">********************</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Signature Pages Follow)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:12%;"></td>
    <td style="width:2.5%;"></td>
    <td style="width:85.5%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">GERON CORPORATION</font></p></td>
   </tr>
   <tr style="height:18pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">12</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.19in;min-height:0.13in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTICE OF EXERCISE</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TO: GERON CORPORATION</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(1) The undersigned holder of Warrant No. PF-</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">                </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> hereby elects to purchase                               Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(2) Payment shall take the form of (check applicable box):</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf0a8;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash Exercise:  lawful money of the United States; or</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Wingdings',serif;min-width:fit-content;">&#xf0a8;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cashless Exercise: the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in Section 2(d), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in Section 2(d).</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:3%;"></td>
    <td style="width:4%;"></td>
    <td style="width:93%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(4) By its delivery of this Notice of Exercise, the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced hereby the Holder will not beneficially own in excess of the number of shares of Common Stock (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended) permitted to be owned under Section 2(e) of the Warrant to which this notice relates.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:3%;"></td>
    <td style="width:4%;"></td>
    <td style="width:93%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:5.75pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">[SIGNATURE OF HOLDER]</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:19%;"></td>
    <td style="width:1%;"></td>
    <td style="width:80%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name of Investing Entity:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:40%;"></td>
    <td style="width:1%;"></td>
    <td style="width:59%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-style:italic;min-width:fit-content;">Signature of Authorized Signatory of Investing Entity:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:23%;"></td>
    <td style="width:1%;"></td>
    <td style="width:76%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name of Authorized Signatory:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:22%;"></td>
    <td style="width:1%;"></td>
    <td style="width:77%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title of Authorized Signatory:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4%;"></td>
    <td style="width:1%;"></td>
    <td style="width:95%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.19in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASSIGNMENT FORM</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(To assign the foregoing warrant, execute</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">this form and supply required information.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Do not use this form to exercise the warrant.)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FOR VALUE RECEIVED, [         ] all of or [           ] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:74.175%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:10.822%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:11.002%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">whose address is</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">.</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:40.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50%;"></td>
    <td style="width:1%;"></td>
    <td style="width:49%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Dated: ,</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:26.985%;"></td>
    <td style="width:1%;"></td>
    <td style="width:14.003%;"></td>
    <td style="width:1%;"></td>
    <td style="width:28.006%;"></td>
    <td style="width:1%;"></td>
    <td style="width:28.006%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Holder&#x2019;s Signature:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Holder&#x2019;s Address:</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;text-indent:10pt;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="text-indent:-10pt;padding-left:10pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>gern-ex5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html>
 <head>
  <title>EX-5.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1.5in;box-sizing:border-box;"><p style="margin-left:5.4pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:36pt;margin-right:0.07500000000000001in;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Exhibit 5.1</font></p>
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:45.38%;"></td>
     <td style="width:54.62%;"></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="text-indent:5.4pt;vertical-align:top;"><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Chadwick Mills</font></p><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">T:</font><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:Arial;font-style:italic;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">+1 650 843 5654</font></p><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">cmills@cooley.com</font></p><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:5.4pt;vertical-align:top;"><p style="margin-left:5.4pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="margin-left:5.4pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-size:2pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">March 19, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Geron Corporation</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">919 East Hillsdale Boulevard, Suite 250</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Foster City, California 94404</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Ladies and Gentlemen:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="ole_link5"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">We have acted as counsel to Geron Corporation, a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), in connection with sale of up to (i) 41,999,998 shares of its common stock, par value $0.001 and (ii) pre-funded warrants (the &#x201c;Warrants&#x201d;) to purchase up to 8,002,668 shares of common stock of the Company (the &#x201c;Warrant Shares&#x201d;), pursuant to a Registration Statement on Form S-3 (File No. 333-269111) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) filed with the Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) by the Company under the Securities Act of 1933, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), the prospectus included in the Registration Statement (the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Base Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#34;), and the prospectus supplement dated March 19, 2024, filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations of the Act (together with the Base Prospectus, the &#34;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Prospectus</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#34;).</font><font id="ole_link6"></font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"><br>In connection with this opinion, we have examined and relied upon the (a) the Registration Statement and Prospectus, (b) the form of Warrant to be filed as an exhibit to a Current Report on Form 8-K, (c) the Company&#x2019;s certificate of incorporation and bylaws, each as currently in effect, and (d) such other records, documents, opinions, certificates, memoranda and instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. We have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies; the accuracy, completeness and authenticity of certificates of public officials, and the due authorization, execution and delivery of all documents by all persons other than the Company where authorization, execution and delivery are prerequisites to the effectiveness thereof. As to certain factual matters, we have relied upon a certificate of an officer of the Company and have not independently verified such matters.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">With regard to our opinion regarding the Warrant Shares, we express no opinion to the extent that future issuances of securities of the Company, antidilution adjustments to outstanding securities of the Company, cause the Warrants to be exercisable for more shares of the Company's common stock than the number then available for issuance by the Company. Further, we have assumed the exercise price of the Warrants will not be adjusted to an amount below the par value per share of the Company&#x2019;s common stock.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">With regard to our opinion concerning the Warrants constituting valid and binding obligations of the Company:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Our opinion is subject to, and may be limited by, (a) applicable bankruptcy, reorganization, insolvency, moratorium, fraudulent conveyance, debtor and creditor, and similar laws which relate to or affect creditors&#x2019; rights generally, and (b) general principles of equity (including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing) regardless of whether considered in a proceeding in equity or at law.</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Our opinion is subject to the qualification that the availability of specific performance, an injunction or other equitable remedies is subject to the discretion of the court before which the request is brought.</font></div></div>
  <div style="flex-direction:column;display:flex;padding-bottom:0.35in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1.5in;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;"></td>
     <td style="width:50%;"></td>
    </tr>
    <tr style="height:36pt;word-break:break-word;white-space:pre-wrap;text-align:center;">
     <td style="text-indent:5.4pt;padding-left:0.08in;vertical-align:bottom;padding-bottom:0.2in;padding-right:0.08in;"><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:5.4pt;padding-left:0.08in;vertical-align:bottom;padding-bottom:0.2in;padding-right:0.08in;"><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:3.6pt;word-break:break-word;white-space:pre-wrap;">
     <td style="text-indent:5.4pt;vertical-align:bottom;"><p style="margin-left:5.4pt;text-indent:0;font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:5.4pt;vertical-align:top;"><p style="margin-left:5.4pt;text-indent:0;font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:25.9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="text-indent:5.4pt;vertical-align:top;"><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">2</font></p></td>
     <td style="text-indent:5.4pt;vertical-align:top;"><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="margin-left:5.4pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">We express no opinion as to any provision of the Warrants that: (a) provides for liquidated damages, buy-in damages, monetary penalties, prepayment or make-whole payments or other economic remedies to the extent such provisions may constitute unlawful penalties, (b) relates to advance waivers of claims, defenses, rights granted by law, or notice, opportunity for hearing, evidentiary requirements, statutes of limitations, trial by jury, or procedural rights, (c) restricts non-written modifications and waivers, (d) provides for the payment of legal and other professional fees where such payment is contrary to law or public policy, (e) relates to exclusivity, election or accumulation of rights or remedies, (f) authorizes or validates conclusive or discretionary determinations, or (g) provides that provisions of the Warrants are severable to the extent an essential part of the agreed exchange is determined to be invalid and unenforceable.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">We express no opinion as to whether a state court outside of the State of New York or a federal court of the United States would give effect to the choice of New York law or jurisdiction provided for in the Warrants.</font></div></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Our opinion herein is expressed solely with respect to the General Corporation Law of the State of Delaware, and, as to the Warrants constituting valid and legally binding obligations of the Company, the laws of the State of New York. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="ole_link3"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">On the basis of the foregoing, and in reliance thereon, we are of the opinion that (i) the Shares, when sold and issued against payment therefor in accordance with the Registration Statement and the Prospectus, will be validly issued, fully paid and non-assessable, (ii) the Warrants, when duly executed by the Company and delivered to the purchasers thereof against payment therefor as described in the Registration Statement and the Prospectus, will be valid and legally binding obligations of the Company, and (iii) the Warrant Shares, when issued and paid for in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Our opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated. Our opinion is based on these laws as in effect on the date hereof, and we disclaim any obligation to advise you of facts, circumstances, events or developments which hereafter may be brought to our attention and which may alter, affect or modify the opinion expressed herein.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">We consent to the reference to our firm under the caption &#x201c;Legal Matters&#x201d; in the Prospectus and to the filing of this opinion as an exhibit to a Current Report on Form 8-K to be filed with the Commission for incorporation by reference into the Registration Statement.  In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.35in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1.5in;box-sizing:border-box;">
   <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;"></td>
     <td style="width:50%;"></td>
    </tr>
    <tr style="height:36pt;word-break:break-word;white-space:pre-wrap;text-align:center;">
     <td style="text-indent:5.4pt;padding-left:0.08in;vertical-align:bottom;padding-bottom:0.2in;padding-right:0.08in;"><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:5.4pt;padding-left:0.08in;vertical-align:bottom;padding-bottom:0.2in;padding-right:0.08in;"><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:right;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:3.6pt;word-break:break-word;white-space:pre-wrap;">
     <td style="text-indent:5.4pt;vertical-align:bottom;"><p style="margin-left:5.4pt;text-indent:0;font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
     <td style="text-indent:5.4pt;vertical-align:top;"><p style="margin-left:5.4pt;text-indent:0;font-size:5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:25.9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="text-indent:5.4pt;vertical-align:top;"><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">3</font></p></td>
     <td style="text-indent:5.4pt;vertical-align:top;"><p style="margin-left:5.4pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="margin-left:5.4pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.07500000000000001in;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Very truly yours,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Cooley LLP</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	/s/ Chadwick Mills		</font></p>
  <p style="margin-left:1%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">	Chadwick Mills</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.35in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:7pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>gern-20240319.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-03-19T18:52:06.6009+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.geron.com/20240319" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:gern="http://www.geron.com/20240319" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.geron.com/20240319/taxonomy/role/Cover" id="Cover">
        <link:definition>100000 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.geron.com/20240319/taxonomy/role/Cover" xlink:href="gern-20240319.xsd#Cover" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CIK</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.geron.com/20240319/taxonomy/role/Cover" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140379763990064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 19, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 19,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">000-20859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GERON CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">75-2287752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">919 E. HILLSDALE BLVD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">SUITE 250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">FOSTER CITY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">473-7700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GERN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  2L<U@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  $K'-8:@>#YNX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)O)VW50^CVHGA2$%Q0O(5D=C?8_"$9:??M3>-N%]$'\)B97[[Y
M!J9702@?\3GZ@)$,IJO9CBX)%3;L0!0$0%('M#+5.>%R<^>CE92?<0]!J@^Y
M1V@YOP6+)+4D"0NP"BN1#;U60D64Y.,)K]6*#Y]Q+#"M $>TZ"A!4S? AF5B
M.,YC#Q?  B.,-GT74*_$4OT36SK 3LDYF34U35,]=267=VC@[>GQI:Q;&9=(
M.H7Y5S*"C@$W[#SYM;N[WSZPH>7M=<6[JN5;WHBN%?SF?7']X7<1MEZ;G?G'
MQF?!H8=?=S%\ 5!+ P04    "  $K'-8F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M  2L<UB9C*-9: 0  !T1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9AO;^)&$,:_RLJMJE9*8GO#WQ20""%WZ+A @;M36_7%8B^P.MOKVUV'Y-MW
MUA";IF;,&["-Y_'/L^-GQO3V4GW7.\X->8FC1/>=G3'IG>OJ8,=CIF]DRA/X
M92-5S SLJJVK4\59F ?%D4L]K^7&3"3.H)<?FZM!3V8F$@F?*Z*S.&;J]9Y'
M<M]W?.?MP$)L=\8>< >]E&WYDILOZ5S!GENHA"+FB18R(8IO^L[0O[NG31N0
MG_%5\+T^V2;V5M92?K<[D[#O>):(1SPP5H+!US,?\2BR2L#QXRCJ%->T@:?;
M;^J/^<W#S:R9YB,9?1.AV?6=CD-"OF%99!9R_Y$?;R@'#&2D\T^R/YS;:#@D
MR+21\3$8"&*1'+[9RS$1)P&W_ID >@R@.??A0CGE S-LT%-R3Y0]&]3L1GZK
M>33 B<2NRM(H^%5 G!F,Y#-7/=> E#W@!L>P^T,8/1/VF:D;XG>O"/5HX[_A
M+A 4&+3 H+G>+89!_AZNM5&P4/]4$1T4&M4*MGKO=,H"WG>@/#57S]P9_/*3
MW_)^1_AN"[Y;3'WP((,,:M&0U6O*J^#P\,[U)P2B44 T4)4A$(0YQ6/$ME44
M>/R&19HC',V"HWE9,N9<"1F2<1(2*+[*O.!*11G5U5&K0&NA@DL>9$H8P349
M!I G$7'RE,7KZAK'M3S/NZ9>I]E%N-H%5QO5&B=&F%>RX%MA*QQR]\3BRH3A
M.A_&B]D3&<T6\]EBN)K,GA"V3L'6N81M!"NJ6$0F2<A?R"?^6D6'*T'&O$ZG
MU6Y@2]DML+J78*W8"YF$P"8V(F"YDY]?4%RQW;RFM--N-RF"YWNE<WJ7 $Z2
M0*I4JISMBBP-/ E$*C*2&204\BK#RH6N47\88Y G]NY? CD,0S!%??6V0:9P
M'IDEU62X9-?ODO$-^3B93I</P^F8W$^_/F"P91/P40_'85=[60F+2RZ_3%9C
M0IL>!EAV 1_W\?> ([L':[V2^Z02#I=[G"U7XP49359_8GAE?_!Q@W^/5]3B
M7,EGD035JXUKCH886MDR?-SIWZ/-I39@-G^)]/P#@BMV&PT/\QF_[!D^;O3Y
M*@YAICV/@@NT\/(JFX2/N_M4!I"3^4XF6->J$6FT;Z_;;0\E*EN#CSOZ-VBF
MAB>0F#C.DJ,!ZTHJ7*AN]O#+MN#C+KZ4D0B@Q2=;\AG*6PD65?+@*G4\M&P#
M%#?JN>+7 :2'P_-U&!%A2H-A=K;95*]?C5XM6>G]%#?J_Y%-M,Z K!80EZT%
M/!GZ<7->"0/SF=P0G_ZZ_HT<A[?*P:-&R=8G3 9+(X/O5^1G[\;S?)(R19Y9
ME*&PI?=3W*Q7BH6VZ):O\5I6EER- ,QNV+A&2YNGN"6_Y8F,7X(=2[;\[#!9
M(_0TA ;^!\94^CN]R-_',5=;FZ4/H&!VUC=2EE2O*"YXMLK<DY==^\<!O$/
M%36)^ :$O)LVZ*K#N_AAQ\@T?_]=2P-OT_GFCC-X NP)\/M&2O.V8U^IBW]$
M!O\"4$L#!!0    (  2L<UB?H!OPL0(  .(,   -    >&PO<W1Y;&5S+GAM
M;-U7;6O;,!#^*T(_8&YB:N*1&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU
M9=V'L<VAR=T]NKM'=R>9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND
M,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&
M@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-
M!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+
MY2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\
MV .7\@%:^*VZBMU7)/3B4PEM(+#52?2$1C&$"0K$OXP68E^$O?VML*01C\9]
M[/QN]*!_[XSC]Y97HA_TOIKS8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C16/'D
ML\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y
M+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^
M7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!
M)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z
M!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C
M$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7
M,6[8"<:1/,<0F,7XC&894IT,/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T
M> \^>Q\ETWLJ.?]74_P$4$L#!!0    (  2L<UB7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ !*QS6*K$(A8S 0
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M6N=6RKV'5[+E&''\GN4/4$L#!!0    (  2L<U@D'INBK0   /@!   :
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=
M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\
MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X
M\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].
MM.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  $K'-899!YDAD!  #/ P
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M<' N>&UL4$L! A0#%     @ !*QS6&H'@^;N    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ !*QS6)E<G",0
M!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    "  $K'-8F8RC66@$   =$0  &               @($-"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ !*QS6)^@&_"Q
M @  X@P   T              ( !JPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    "  $K'-8EXJ[',     3 @  "P              @ &'#P  7W)E;',O
M+G)E;'-02P$"% ,4    "  $K'-8JL0B%C,!   B @  #P
M@ %P$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ !*QS6"0>FZ*M
M^ $  !H              ( !T!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ !*QS6&60>9(9 0  SP,  !,              ( !
MM1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  _Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="gern-20240319.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20240319/taxonomy/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="gern-20240319.htm">gern-20240319.htm</File>
    <File>gern-20240319.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gern-20240319.htm": {
   "nsprefix": "gern",
   "nsuri": "http://www.geron.com/20240319",
   "dts": {
    "inline": {
     "local": [
      "gern-20240319.htm"
     ]
    },
    "schema": {
     "local": [
      "gern-20240319.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://www.geron.com/20240319/taxonomy/role/Cover",
     "longName": "100000 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_fd658c12-c345-4597-b50d-ad46331f0ffe",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gern-20240319.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fd658c12-c345-4597-b50d-ad46331f0ffe",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gern-20240319.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "CIK",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.geron.com/20240319/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000950170-24-033921-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-033921-xbrl.zip
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M<05)R!NV0FAY&0Y0J83\$'H*F<0*:(&%@Q2G;D](N%,&[D>5#G)]&4I/,0?
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M6.-LE^"BLSMUQ*K>=G6#.$;:P="1Z9X2M"1(I][3/:N%,BS !C* ?UC81TO
M*,RD' R8"(,HAWBV/S$W#A^BEA??B$@:<P6I<T,N6STD8%N(7/W%$6@UQ%,"
M-$J&X)-) *7], NPR%')/^1GVGL$;]M(<S4CVP,O650:<T4D@$<6D2W-,[8+
M][T]+*_D/EN8%&,95Q"IEP3#.9Z?,_A6<.>J (UT5= [^W,$B);7*D!#08)Q
MPB 1V03UQ?2>X7).OZ<?7'Q%<.[VA^$V.7,6T;E\>D88P-4!*(04B/:X'[C
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MG1CR3^ :3_=Z /&4,[AC>#KL\"G2$.:\ WTG&86 <-@)H)/ZZ=B4T-H3[/-
M4VO>2,D@CS'$TYWP[H7\AK4;N=7XE>3"Z^NQV77#U)%,?3YN:"ZT[<?M=_#'
MWU<,C^@<NIH3OTK'01!A=LL1L,OI])&2&.VPL]4M9C70/Q)@<G7FNM#=@QOH
M[OB273%Z[R5OH3SL4O.*(-\RFR>#-ZOYA/H*C/+UBD!!-N<Y,'K)[#.0PB#!
M4R!3&-7QF$=P>,ENZ0/9](0SEA4!_95Y(8Q=/C8BXB6OM$ !4VU7*9LC&+?,
M]L<P9I>_X)66R[Q=I2!O[>78!0"0S2<D?8GF$^6,5&Y?*>AK//,"X(S$*QTM
MUIQ911!'$6-\O00K3=O_'=OL(W'Y^E !4VM:$521 %W!7$-=/4ZU71U3TQ6%
M%87_A[<847?C^T<VKA0NK-@I@^P['B+Q>W!$(QCFJU+<Y7=5% !?*/A7=Y1@
M[510,*EJ:/%GR["M(5&Z7!&D7)[VI*2NAG0NSL#/)GQ6=$(5A=+UJG(C[$3P
MNEY]7#IW-IEAS:2N-*MT5'^<8S:#[.QG1A_".WB4"YOHW^MJZXH GT$'<V/=
MSK=G"HCR]4I9_.3Y^JFE8%+'6R;]#]:-N+_I)2/9U@RV]P2PO:I'=Z\_N>6+
M\I*1O3:I./_A8DE)VA-?5D'BIER)A2/^X0,FQM<;66@ MFG$E$OE32O\O_W)
M>HVXE?K!77=.P:WA9/RBQ#%*/*/8=:H3Q7<\=UAE"L".(24N4>KS!Q1[190A
MX?>0\4AJP8X!I#Y0XN20:(L*PHZ0'QTAX:FR7O.H*CQ3A^$.>7_A+@\9A5)T
MV#&&U!>2G1W^&>34B/V>0.H,Q=X0N&L\?NCJ ;Y(@AB-?SD\7HV@LA_OX!3)
M7E'B]O#QR*++?F$\^D+<6=/!9_M.A=!U*M*.W*?N4.(/<8<(/,8U#H<,0RDR
M[1C#^I.]Q-G+P9_M0A5BU\MFS_0&3GPB<(JXU\/'4BJE[1>4Y#J3C:8-'#S
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M^6TX+=_QG=48GD6(6=A\968X=Y[O/E%%EU?SE,'8&7;>G/ O9US >I3S/^Q
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M[UM/-_VL5)1ZKLL2GH"U \5@IR9?.AU]I<%O;0$>MF?BFZ<,D"):U2 /<"?
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MHHCMY+60RV0AM?= K;XC;S5AC\&PU+*835G*4ACM8!7J!OVJ07PSG6@5>':
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M2H(J>M;)H1C4)]^@-4X+58S7A@;,*3:G"4-W&$+#;1G;HNCPO$I+^ "N#-B
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MR=D!DHEP"AH-@;!M86[*8;O(RJ#@7=>0"-.E6OER-SC-GD9NE%>JXP&S$@;
MJ!=KXU\QS)3F8<\RK4K#"+H4RKTLU= ZR-=F,95$-!$]*TZ"P[0\E]*6J731
M+ON! JL!";LRL3345;$<<U^$2]/D;Q#P$E4U"'O%KB+*%!.IT#"AZ>^E]'[2
MYO#@+.7/L&,_X)%*HK\9%5Y,';JJ55TKS,>/3#YT%;WG'.GHES6[K'OURG[9
M[*KNS1T.H9&FE N(IQK3 MUM3M<[=*=SJ[<1HO%U[G7X.BWY9O>AHY=>XUY6
M<_^-_G.W=D'HI=[+VF<_#[O)6T#6/?K*EM+PHN+DFA.'^>+E>5N>4$#+!+/,
M; ]L,64B:54S!]TAU;QA%TAA0#( LR#A,]N<3TC3U_-U$NE*'7,K3KH#+ON0
MR(DODS?&\/=C/G5WTH75<S@H/B #.N9VQ'53Z:[H>=%!^W81;QB],0L2C-VV
MD:._866D2WTA8W#KSK2)EX\B4K)C QN#6V-P:PQN;=^<?<C!K6XXP6)'_("+
MC76)?2=*0R>*A8IO*>$'PMR:J$2E%GJ+I4Y'5\T-NFKN8UV;0,7\0KMW.QX9
MS.LAY*I4L:H,S:_7/Q<-&U+5+?V;Y]#T#'>B=$2/0#L'>;@&J8O8]K6#_RVR
MCGG=$PL>]M&,CM/;.(WW\3">3"LM)NS_,K4GP.I^I^>*LG'Q"GIKRNUN.6HE
M!C66^FN7RL#(#-C'9<T$3],5I_.Y\^K'59!6U$3FN? ?-)?PB&.Q^",JR$[Q
MJ6(FY$T8W^$Z1-B/=$9G,5-+\3Y072QX=T&N!4KT\GQ93.OJ7B.W-(*))83&
MK@0,HZ,;QC@6*,=8EXN82+5RE1N"* 9+AQ8\^[>P8DJ#S%T+T =.*9$YT8@[
M@$Z6L(7C*"L0%^$B8T:Z!1\Y!0(%"&?=M;+_&$1B/%6]CTR+)D\D@UDX('.;
M1.WGW*&'I>/.PQ:, Z55RGYGD/@GSA>)>^>CT[NV1C=LO9B64%CV'<<H;18B
ML7:=LJM1-J0ZA>%@SE6\28HBI\B_[1Y(YGB[B,5WCJTU&;5I4KSBZ(\F.67O
M$EET,=5J]DG>N!E53M.:XJ QL\3%(4?<M$A6MF%TTO,'*H%IDAL6;^A3XY"5
MK6Y"W#$]SV1Q] A<Z*@J!VFG^+XU5!D^(8+9QZ5/8["'^:RQ5R)RZ[OV5W\*
MW^<@I>X\NWO-=K5[J;KI'2MW"L<LF'://<HK'\[@W+H=P(.)91$5@X> 6P]^
M2&VM]%M%G&U )V%;:;FKS<>-<Z;#MI[!Q>'%(H>:]'/6#931::0SQ:;KSFS^
MO_(8/\OXMEL=W"/J;^GT%G3B(^MP=GEJUX;JT//O"AHZW@+AQJ102F$K-%(D
MA(Z7R9NG=Q>E*[N(J5KIN20@._UG"?*.*)C;&M!,M$;;DJ<,J0B=@E2;/&:!
MS[<3_/E%F[CQ>]+ NJQ"O+%BQQECJ1VA34/\F2[\.A%,NXEQ8%02A>[&180Y
ME,31&<O1,*B2>&85G]AA!:!+[&]F!2X*G@*\,A*C;7?'3Y]AURO3]ZK5^1N7
MD$0P7O*68*V5MXSW4YB%X+8W%$$A*HC6Q%?*]WV2#>\F)=C1#6H,/7>;W#"=
MDAQ2A1I[P+6IR9(/KJ!;N(%.A!;+8!]V2"]H[;^MI9(B_U5%J\&66&#TL"&!
MW+',;LYT4F;YL3(%'JHIVT%>%NEYFAAK%\VD*=S.1$2R5PQ4,Z>=P*V['%,N
M;SYQWE>T;222S1]JAZH&P]&6'D>!Y:%B4$3CBR,BBY>4T(8X<KV^A7?"Z+FY
M%<_-O42\.=?-)V+3?L=LVMO@22]:A-ZV-  JP<5*ZX[8IT1MO,MBXQ"U95([
MD)X43SE>[AJU #[\+(^9VD=-,X+FZ!]+KA]#Y_$F^'5&U,(-;9)7CR($OF,#
M&U$+(VIA1"W<4XWDGJLDXEN!K;^-L)&K9!90(=VH[\T4G9 8LF0@!:YITOBM
M7UJ<@V! -BD;]DLW21&6IH4_R/BV.M&Z6O)D,%_ZTC0G^AE;?VR#4$X0J7$A
MFDY@AAR"!MU*L3%$9X.-U1CX<M<^3N=@F&$\BRO3L#Z6K5KCC2]5[SCJ/LA%
M790V*UC2G]RK&(/-';L13M\WFZP6<N0Y9\K0)E!D05I5MX>Z"_NW;H_9S#VB
ML;0MP2_)!JYV;*7>2-[9)#Q,!BB.T\/GXJ?/UX:G*CPOD>6"MU7K>H 65RQD
MMX&D\3S\M@=7J/IWU7>$Z2XWF;INUK>SP(67\<W>&??**TSZG IG8K*&K?*W
M%EX3S&95\.]'I\HMJ3#W4H<A=HD970J2%K5U?%IP6MPY^?F:FI>(B:)35Y/5
M@VL</.XK70:V0A></]=32O0SC9KQC"?S5F"C]Y$$V;,M/C0EW1A?O.RQ[7@]
M8<,2K3>EDQ4656+R]]42(V*HMF#PDTY<ELZP2K:-8/EHT[A%:.X'MN+!R!;"
MXFR@ES0BD05>A7J+:6A%F 6_TAM?CJ7Z>R[IIM:G6X#F5I*IXC+@RB%H@ M7
M.U[U*V GJ+]AEJB$5%F;]G,;509:*$)YIH*(8ZI&R=M<HTO$H6;AE7WF;[BD
MK?3U=U4EZA_"O/F;*K_K.OKTZ6T\0&L@H[9-?+ E43[F"1Q36+,O3H4]<:BD
MC_GL(-K;F;C@AX^_?SG9&E!BO =NXQZXC]? YX(R<45X?&)IRL"+SVBL;AVE
MO.0.,DZ#\,,BCF++5N/7UB89:P% 5L8RS0R)?:3ID6'"/8+H%+H@Z%]\JU1R
MFU3NQL$J33P=S)#M8Q[_:0A5.*MZNHIMEQ8JT?1&6+1,&?2BJ&9D1O-51[X"
M?-42I@:DGK"[B!!$@/&,S7-3"V0#ET6J?6/7WFCF%NO4[=!=]*61MK;"2+M\
M5&4\"]G*%/B0,L7U%0JO] +Q\-\[(ZVW=!2ZB,[>2BER1&(Y&C&?@)5%BBW4
M=VU3U7SDS>5>J^OZH1"48_!.G\W!*8EBD(BRB&*!UMV426L7PS&UATO8N2FR
M*" V">;%8N7FQI\J+JF Q*'4YX73^A9%XFF!<P=*XJX1/HLI\6UU&[+*LE2?
M:SY$_N,&W<=J4*XOW 9O54V,36FB7C?9&"^_LY-T=/@HHJ\[-K Q8#X&S,>
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M8GJ[I-X[?[WC6E62X8_LRZ3,)F#.HGK+H,"B#!9O$@RMA:^TFJY#-7-M5IY
MCX$41*GAI&T3:Q@<\U)52$8 !W6E55D%7!(V P%5=2ZFZ^#*L<%YPG<##U!D
MT6S[]B/R!&8T*"2C9RB3'^JXU@9J[Q_*1^8WM%Y JBR5&KW"GAKJ[&APWX[!
M?1_M[4_BL_FB)11VEBZW6WO[UIB(0W&QETZBI- L%CBOR*<;RJPORREQ=H+<
M:9^J_+NYW4C<.BN?[<F_.CG*S#RI_U[$T3 [%]ZH@M(*+E8N5C!XM3*>$@$T
M]..FQKK$S!BBIR ?+A@109??FJZ-$N&6),)]A#_@&4-&-4/6\9LJO^MZ_XL$
MTM^I6FU!0IR@!MCJV8)[9D+\0L<6$G1=4WR(QN$E4!##AJJ( X_9PDLJ44$G
MM"J:TG )!F+&)&:A [ F,>(QTPDS*#.3P"A2IB;T.?M[*$F\[(V6^E-,I50"
M?F%*9QAJ>6E$X'ZL(."$<?^INA</8A0&MR4,[J,T^+V(OM#I<I?.#I ,Y05?
M<%607+"TO"1@I,R^6YO?,B[ZL,Y<F9H$A'PZ96>"+V)*MI30E3];!:A//N8M
MU*?C4A.Z,K);_,K;Q._V]/CYWND$&?J"%(=CQ$AMD@<U E1N"J#R\E&@'79L
M8"- 902HC "5^ZO"W$<=IK\0[5;='%Z%JXH]C;VD=>L)3P;)=-UP:U=WU]!C
M@WF!%H24ZL0 2%,3,2E3V6)5,EU?%.7W"M]?)I@@AB4MYS7_=:&G55IWBY9A
MPVA1X"FH=C:N]?%;])7'N3WL0IND@^>.H?Y"*:E+7,.@V!RG^>3"M6>3;+SB
M@>P=NEIUSMCPPZ^#N41<#EMSYV:95J7!YD^;4ZR^6994C@O+H,VPH-FWLOA#
MY=$9?(H[A3S<TV(QQ1)H>'5)\H*K@=DL:XP+P"'YX+1FBM!EBODO*>D8ZRGN
M<^;4P#:77<P,TH[8R(S$^M[T#UW.,/9D**>K,^4H$A*LKV9(0WM/F=M(/?9)
MNG"%\OQD)\&BJ*:RC:]Y5'+K4C%2K.? T$O'-G<J]A*G8F&KF.O3!HYOF$CE
MJ@!PLA46#*9L+^OYQ!H"%$Q-J7J)FV/C4;4%\&Q65=%4;AMB8D4"0EN9U! _
M@9S*SLXOFU"7\.EWQC2!A3,IR((T6.8O3#NDY^8I<[%6&-*M*0<P&)&KA6<\
M1N0 D:0RDU,[4SFMC33)R[8L:F[$>QDR6^R,;/LLD[$5'YT5;Y.HJ?K%%>XS
MES482)[AJJ1\8=U5?( (_$U"50X'M$2N7>RL#;9B/+NIH0WR.32YR2^%+C65
M#2US&0WVT&--2QOKY&!F40E-N\]HC"3^4MD"06/>D:P(VN81L['?(&FX0B66
M$9VOO+#Q4J*0IK B4I,G%(5EIX/EVR^1?_B"E0^O/I&$.S"CII#P ]9)[E-@
M@HCT)HH*"LA63!?!P#K:.YZ8P*ZK/5'Q?=67Q :RI%U/';.\3/*8J<'J/?-'
MDYQ*Q4U357/*%9L'$LI,P>'K5P&.W5P'B:Z^O*TQ YZ GM-,%J!R/,\B+S$#
MZK0@AF=2L$@U"!=I6:;GJD?J7B)NZ?E =O@G<^FJRAN_\=J?;G+X6>:VCTXL
MAP94A+1R%/F&J*1(L((,_?L&=Z(A/,"KWQ;>,5%]2B:&7;=RZE:(FG,2!H?^
MV4V5QV42EEOW=J-9KMZJZ^WLM:M/\NC'OR5<_7TD7P.E&I3N9/]341#K@[TH
MJ[NO9_M[@<*,NI-)=RRW>+3GU05!"@IA9C 4XT]>G!B)ACG%>&KL5T?OS5<@
M'+CT#?K474B0;KDU-9B\ 'R_5M$3%K0L[L2S3I< 1MK+A7>1*U]YA_/!8!['
MBV]5&J^V34#>/Q[EVSC*V3T\Q[\IPHP88A5_F]Z]/\NW>LEZCD/F 7A?%EC/
MK5*9E,@_R#%@JPH<XVDY>K:73,SIM%6'3);_9QC-AX:(!O^FRI(0AL1KY! Q
M,86^\8(<,JOU?,YECWPS6?@111(X.67Y6<DD'N*)E,Y$7\\44IH0L:1U/,@S
M/7TG*&9N:0A\[D9O^H1G30HXU*40)/3$%8WMT5/;9* '/'L7$M=T5#!C@/(.
M Y2O'D6T:\<&-@8HQP#E&*"\GPK=?0Q.ME2$+UR**=E5;6YC;4MJ2I%Z@J12
M7GH/VD2B_-A8IZ7+=2ZA*3S6Y*P$N6@1Y0LUN32?8%=+]KHB\HJLM6+V'0.6
M&=87LWY&%U'2J.YQB4<J8(4ON%13(\=7KZI&V5K-8JHI)M9JQY;I3//4A Y0
M631 3Z2< D62_FUIQ]L:(OPOW_?!W3W]&$W$VY$H]U&D<-)XZ7R];['D SE/
MMX+>1.SVS'4ADG"D #)MD=0PY"PGP]5M_1*0)A@V:<RN@BUHS[F7U5!)2->%
M<U7 O""^V0L^0:MV,5QDCT3_>Y#"49G>+%1-KS 5/2AV-%UM< P?\)EK296-
M#YJ8^G_*I]7RS9.#^W?BOAI#_!WO6MH]_E9\$[W-"D3ZC!OD.AMD3]VV&+YT
M$/P MO<Z12;DV>!F\/60H%((QLJZ-_<6!/)?6,\05_3<..(\R5CYHI$*?+D:
M)PQ.(5=7Z,M#1+S)\P5%A=N1']I"[6$$3H'Z)T%RC9IF5^8BE ,U)*HAGW.@
MCY*_N4!"<L4?V/>!0C@[@X/B4NP<IT]MPJDSJDO..F98:_[K[$PGB.<_D5Q>
M#%>B)].K\V*5PBONB*$W1<42=-A4RBWDRLLZ#\:_S#!?"6<WX550V4]TAJ$Q
M[;? !;@RA9 E;,U7M9U7^ .]HK472#Z7PN:^=_=0JB_'9C>U*QSCWJ#J6 F*
M"'8/*QC!:?>^E_3HMJ; X:2T))N PBVE9G<NZ0=$/H [#UEZ<H;@K<B-RUDE
M,B#J]KSDV+#*Q/ 8Y?FUY/GT'LGS_VUL\O]SYZ)ZW%S7V5RS>[2Y/G.!@RTH
M 9]=:05QD(C<IFO/PI(3H]$B%M>S(PEK94!&1$^72>R.?FI2X89NFJ&XDS79
MN&XYW\1L(I( _J3@MEU$?U*+Y1OX5?T]A?ODTZ?/<73T]!#N2MB]T3MX_V\Z
MSPH88_D]CMZ>1*^>'CYYQN4@:KY.!"B7*0S;>>\E#4%JP(E%V+Y/6G0YI# <
M';X^/(Q.#GX[B/;0!?S?1?D]>HMS@]ZS222N'9BQ(J=J:&F9P$WG"BX1T '3
M?BM)%7[Z^O@P^KRN0;RFL,Q%'B5J-7'HJ@3Y *@- @GBC2:5)?::/,,G0(VH
M88 ,(E(S)'X/2S<,7=83FD-O @G9C2H6(FH%NX!IQWYGS(A,TO'/3GBTQV4W
M\-62=4":D"D6$FS;J<:9->HK4S/M#&)7C,((0P=; ^P>.*O5^6#Z#ZXDMWN]
M;AW8^JPLFE/>0U(>3.B6T+W\3I/^B@#);R6(<+N@LBW[UI[;=ZY?+D<SJ]EA
MO5:$=%Q(1L:5U9K@.QX)RNDE^#A*LT5LJR1*]5/<?JA_\]8TGR0:&>!R8T!5
M5W@G]QDA$+HB!".JM#C'[:/5FO[A62#0@)6CUO<^YXH^2SG1 P=.I%4@44!(
ML<NMOP]>@9DUZVA6;\-I(2C&=U<&:&X!6-UGB^[LM-#E.-J+M!36JSGAH*-T
M@;!KF&$T%]TT0>/6UX<"LL%#";/&F/^6JQ!]_.T+%$;UKT\.7KUZ119DM\-D
MYF2I;GS)9;E%/:-F;@1N;_2A+1IYFF7G\^]&R,:=R=0GAX\B_K]C QLA&R-D
M8Q<@&P_?%G_ 90T&U ^F(O64E1XMHZLP@E&C4-61GYNBA]Z-WYN3X_)_\-7!
M)3[0O;:V\(8MMX0BDBTN*E8-L$0BE6G<0WQ%2EEN&GE4UZF9$RK2^*^'!T<O
MV2'>WZ6^'MVXTM52+ ^BCX*:. ] K9LIF'-X=T?+;&F-J("1#5(2A^JZYGIV
M1]RK#:/W7&?D[<;Y$:XNS..;M;56J=(^T[BY^M$N_L:2GH(^ZJ(1ZW90GYT4
MK)^!$Z=5=(*F.D[1D&/2RGL23FF..8=&=MS,%4"RT!-](FON5%+(-FE9OI>8
M&HAO6K_K%=-)FHW/:=LF427T-XET2;QH<]\N,^:2Y)'A!I+6[:$(EOHJ+C[Z
M=<A$.76GSO1Y<1!%'XF$B[9156-."YW1#K8"\V$\]%?/>#AKE%!B/ HZ&I@T
MN*Q]/V7,QX63;6-)M_P>%),=\GA>UVW)0;*TYE&P1\L+A@E%0&<\- FNTH<7
ML:3TSI91WEVQF 0)2?* OL"/R$TV'/S:L:^QNWL6OLU\>D'YSKS1*>&9NTE)
MSR37W!8/)">-R[M!O4&63*S8C4M2.!?WB)=,&]FZD >>#O?HM+>?P^4<WT-<
MSEO+-QZJ7+L2R+/W90\V\W;NR]O?;.'(?=>@8W^G.$,?NFY>9%EQ4;T>C^D#
M1D<%- [>)?/%RW_'>]"CTOS"GO$M<X_&/N+)!,6.]Z83R=%KDP6T4QJ% /3P
ME[#> ')W].)6G+X8&U@5IA8S_(=M!1<JB(G3G!('B2.GJ.I]3:0'I/=AQ67?
MNAG(<#9*+0%[W,^%1\2U0D[II5 7F3:]O&ANQ[&;S+&X0\S\YQ9QQDJ:)=E8
MB'+I ;)D_>F'_$NN*L%QDG[*U;"CZX=[U7%YU;VX($0Q:^C)X<3R6F*/T#+U
MSF&R/'8E'."YG1F;3]H=H*E3!B*/.4R@NY6IO$AFL%DSGP-L_>@'MTI1FO?Q
MJV![HI$MQ/BM%S<N8>$75"R]S=!)FX^E:0J)4S.5!YS[!ZC"ENNCA_1^3C^>
M<_XM=D1E-G_?KQ7NOX7S+PR9B*D^*>P"- FVZ'1E=Y$QG1V)KYT0_4.94%^
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M5Z.IE'HWZWMITWOZ>!8"1CEZR26:9T_>^.8$<>;)65'AR*NJF*7D2:;+R/'
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M%+N>2G %435DYO28>.0E*S56O"@92^<=33*=#,&IB*$&+._JK(64(D93SK:
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MRNT\6W4H<-K2N?+%,Z=B# GR]J.C++^R+!_QKP^TO,R)(/B-+/@,8P#CZTU
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MYA1.G-Q&<&M1%FVOPNQA]2FH"\]Q>-BPX6:5X,O)T>)O3H(\#/[I_1*G(]B
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M].1Q,SO'1SR4[<*3C!DV YAPX65U<)J&[**90DG-"AC-(3 .BD8<V&_S#"@
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M^F[B.$AT("(G3[@,T.^/X*HBIY^<SL":W;6!U,GW:L+[\B"LQ^ABT&5P$5&
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MX++>H#/FZZE0G'PS$WYRJ*:V68>N;V::)8!KIJW7B5BOX[3,BGGHE EV7LS
M#_/B=!P4.H^HB!Q+#- RX;YEEMCL8YJEY079RE^"!)S&(DA,'U,N G+?>:;A
M+Z:OWT^_; !+'#-<+[YAK&%GA(3<FTFD:#JP#"N3$-]B[+GQA0NGS\O1-"J<
M\EM=:/0/1^5Z X=0U)[RO"9RR/*:F0R?M"[5#5.#2OM4@XTD$?$&07?V31_N
MO\EP5[EOM"\.D7-E4XBT)WEEMFQHT'UR[G3;UY*^/D]7PUUVQNT\35="9A7
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M]R2]CE5X@=9F8_"HV7,^N=13M;2*2!K9&I4Z/V= 2^=[89GIMJT@B!%,9*3
M]$[HH//W0S 2:&0P5!R]2L+Z7VD;0-&\?0T_W^3>) .%9/XJJS?O#G6:P8*9
MKQ(A?<F)$:;,<^SHJN+TNF/J7_OHWVC95GC+UN6#I#])"U;N:5GP[L(HX::
MY8<GD(#BXL/6F'MCD&;4%!AD,XYX5VG3JQ8EGXGX!OOO1HG^R2=R*3J H.)(
M<GUB+O/Q5446\/[R;_#_>WC7I#,^TUGE0[IOLV\[.,__,#_Q GFGG$_Y'N$
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MT@%,:DARPO?B:!JA[11'P0BNUP(_RT!.$TI1R-=^XZ&)44'/C>'U3IXC0F"
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M#.K(J;/\X+F19EV:C5@E,$?R"?PS^$&V#):O4DYM!--@(WNN)VRQ5YEWA9Z
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M.7%7V% _@Y0I@)BE8^6F&Q;F-'PBGJA8U%7V=_.&$=K5.JA(=4#(.+'@FVZ
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MI/46#8<5UWI$WY\$5K[=P\KK5%HLT2M<E][8?PKT=Y>%#Z^ E5,Z;'AG598
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MARJT&A/$:@Y>UUDU=  !]AUC?X):-0J B NI7CU+$_"ZID$4-P)7]] 0'(W
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MPSYRX) M[GT+IBH.O#,P."]?ZG(<HJ'QWIOEN C_^P)5^P88 "_X>L.@']A
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MT9@9,T;[IC"7:MYT95N8EJ/"=XH#-:5TX,5P')-<.>UY+S+%ZMSLNVPJ,F/
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M%0=SD+ZJ".;P!UQ[>#ZIRF"IBD525?!U6)9P0LK^[\+/M(X^;$)2!O 1&B]
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M C\"&8<6!H_U<04:X/.]%\8B4FC4K-!F 'H<117>WOU7!P<T,.B>9,/T7NO
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M&L$4^;#7B,T:V&8GG)PDQLM4GT.4%4:"RHQM!IXW1Y@8N:+:[P^LZ)_W]R?
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MNKT(:)L1U]?_3$=G*EBNH#WE-QB%Y^^[X80^Z(C#,7!1E$*$->Y(&.U@X#<
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M1U'KJ@AO@&])L:>I3L$;1;R ^Y.Q[U0G-=>1!5"/D<X1V(KSDNM*G5]-#*Z
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M&UL#&X!?(2R+CV'FU)\+#B^"FYMD(4KAX!IVT01T,YB)HV%4C+TT^NQF$6G
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M8!YR0<!PL7+; "^ZP2Z<L@'72V_QG+3L:AKZ\_ 26X XB!*ZQ6S-WD=/B6?
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MT/6CI>O'C]]-\_CZS__XXW?S:I'^^?\#4$L#!!0    (  6L<UBVQ?10V@\
M )!V   .    9V5R;BUE>#5?,2YH=&WM76US&[<1_IS\"M2I4VE*4J0HR1:I
M>IJX=IJIDV;BM&X_=< [D(1];P%PHIA?WV<7N..1HFQ)ED1)868BDW=XV5WL
M+G:!9Z63J4N3%U^*DZF2,?X5)TZ[1+UX]9_V8:=WLN>_X?U>:' RRN.YL&Z>
MJ+\\2:69Z&P@9.GR/^BTR(V3F1L6,HYU-AF(Y\79\ F/&NO3JE-XVW9Y,>AV
M#G4V3'76GBH]F;I!CQ^,\K.VU;_1&*/<Q,JT\00CG13+,[<3-7:#P\Y!X8;C
M/'/420UZ77P-#7@2_VXL4YW,![_H5%GQHYJ)G_-49E7#4>Y<G@[Z1XN^ABGJ
M=KK/#KO-_WJ@T*DSUY:)GF0#;D;$T2P5?5&>Y&;PE>\PG$VU4VU;R$@-"J/:
M,R,+3]3,LSW*DWB5@R;1WQ@M$Y;33,=N.AAKUX[P7F4T\ZNSJ1YI)WC%J-N+
MD[V"Q([5E*-$540%61(=)-KND-^V$SG/2X<QSU0\]./WNF#[Z3!T #.)+*P:
M6%5((YWRBTK#FVKL4VU!0Z+=?% UKUJA65PU\\,?'';ZSY^2S/9<?%&CPX/.
MT?YR(WPRYV:N-(=D-@/![9%1\L. ?[;IP7KQKR&.%U5G,:0:E.I4&:<CF82E
MAC9]0@N;0W1O2">[5U1((N>Z^G@I?7LYE?%,1Q_$#SI);$/E?O>2^6502>,Z
M4[ \CM::OG]/PPVT S/1A22(SZ'@4DS^N2>.#KOB^4%?'!X='FS7?R&:*"6+
M^&N4YXF:=Z(\?>#"^4QQ?/U5[Z@[;,I@K;^_1;_[_+'*K]X*\8%V\3N(C6Y7
M($S>_I7BGC7B09S)\68MC(M97W6T'V>^MU]IV>>[DNO$>#]($TU%[[@E]KO[
M!\MAWF6XO=I";Y#1[Y3),_$R-\@FI--Y]HAY/>X=BU?2.O%WVC9BB5#]V[Q,
MU*DT<4N\+3&7V#_L/F()O,ZM4T:\1-[0$B]!PS@WF9;B^."@>PTM[ZTZD/MM
MU&]DK$&>S&+Q'9XD*E79X Y7^WUIG1[/AT^$CO_R!#'+_Q*=?3B\0PF\4V(J
M3Y60D5.QD%9$>9E9E0B7BW.>H"6D^)M*Y$P:A8;U<['CIDI\_=79?K<7#3\G
M_KU2.G[YF/QEGA8RFW]V;G!%X7J)Q,/=EM 9!)9E*F)YS;2;"DON)A^+LB!A
M[^A=<=!K'1\?X__GPDXA8TNOM:-%25-TLRZ//K1$(8TXE4FIQ!\1 W1[K+\[
M&@,0R>,245@LL$9&9NB[M#;OPM.:,IJZ*+&U2:L")<];W>Y^Z^BH2423 /I.
M8P:AKIU O.6N#0%@$EO2&\P@Q<]JHJT+VO/624>6YP2^O,Y-*MZV^V+GM89\
M?LP[HM_OM_>/CGN]WNZ]U[3UC&U,\<080HR]OI'DWJJH--I53N_5&18^F_!:
MIMK:!V++@=3-274T7[( LCBS*M]O(D>6TCON]UOD6"44@0SSOLMWF84-NDR2
M4V%R6\!IEA8>-$I*$B!<*;VZP(4$\?8/[J-LOR4O^U/-T]T+%V*!9,GT5Z1K
MRZ)(O 1C2:' <K[36G4D#8?1].P_(W@6!_L'.Z/=:IN@1][;8,7*A-?+5B_)
M2'9</E'X8A:CK\C)Z\)]7=1-KV=G:=IF('E$9_=W'\S>G0!.1N;%]^<C*S?5
MT+!"9QRSSD*(J\XP9$91+G31J$3C8UGDWIOLR-V/>17JTM1'TF]J/J9H!;I<
MA3TP@9$*MD(^/\.L_FZ(PYZ7I3$TW,^*KNKJ<.=Y^Q\8,MIM;BK>$1X/$?S1
M6=Q81Z"%X\&L&7D38:,Y0G(0I20LED)X/TLR)U>IQF/0[&U^)]Z%H:-1SN9F
M%$:*T3'.HY+8Q,<@-7QJ3(MOJ4HQ919+'DAGD)'O0A-BFKPTXGT93[RTD!Y@
M092UTLQ%;H0LX&H*+"58@"!4QK=B<#OX8E2]>X;)(3.HAK60X4@E^:PCZBS%
M6LSJG==$9266,T-#$HM,$F&AAM*51@6/(4O\S)R.D-U6;6I>(8E1JAWY.E!1
M,B.YT=!NF83^T"M:8.J-)O7+2PT5@1EEAYZ."$LB(V38B*/A9IVGFB2Y2F)3
MZO2]*$?P/?B$9YH)JYQW7'H&0=9O(3M39]B[:[6(H>*GRJSA'.$+/2B4L>R+
M61L<(L&EJ&:&IY>=@E8<:V;4KZ6VFFB'(&@PKWYHQ!S31"H?=\0WW("8E5">
M,;+/4B8BE9"AL0N3;5JI7#4$D,MB >TK&0F1QOVS' X1ZE4H/IF&18!:#($Q
MV0["A)W->\FK^L5S,U[VB/81[@+OR.<;-9&&[8]<4>5)_%.=35@_EI-35K/@
M:J I=9]*<\]H>#(+)\8E>16!@ >!3N0MTR[BY&7U(Q-U.M9)L).81.(-CZES
MUD%!B::/#!')$B%0@V@;]A88H(FT90<*YR3@EE4C46\,\J?E<X.%@6=E.O(>
M%]2=2IW4@U4,KB0X'?&Z-&2["\ML>N) $GD 6&-%14WW3,/7D"6">B\,[R=!
MC4SS,G/>R_N(M#[:@'/R;*UPU=@7&\QM+?BQ6C :P<-G*R9,JX\81#O8&-Y
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M N'CZ88RK9H!W=U;!4GR8=2R(A(PSEI>Z(0N_5W56TZ,@LJH"I@.:55T>-3
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M+FAT;5!+ 0(4 Q0    (  6L<UC2XO?_*0D  /AL   1              "
M 2(8  !G97)N+3(P,C0P,S$Y+GAS9%!+ 0(4 Q0    (  6L<UB6+NP%+/
M ""."  .              "  7HA  !G97)N+65X,5\Q+FAT;5!+ 0(4 Q0
M   (  6L<UB?=Z@O0DP  +NW @ .              "  =(1 0!G97)N+65X
M-%\Q+FAT;5!+ 0(4 Q0    (  6L<UBVQ?10V@\  )!V   .
L  "  4!> 0!G97)N+65X-5\Q+FAT;5!+!08     !0 % #(!  !&;@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>gern-20240319_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gern-20240319.xsd" xlink:type="simple"/>
    <context id="C_fd658c12-c345-4597-b50d-ad46331f0ffe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <startDate>2024-03-19</startDate>
            <endDate>2024-03-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_add42bc0-0d89-4bd4-ada7-3913936871af">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_a5df678d-2a23-4a70-ae9d-8fcf8e85d4dc">0000886744</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_b66c2bf3-46c0-4061-a2c4-e4a19928b8e4">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_6d1ddc66-9812-45f2-b332-b00054f6ce70">2024-03-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_4ce76943-8eb2-40da-aac8-da7b38be58a2">GERON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_109fb3f7-aff6-4e7c-a44a-206479e4e44e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_7da3a392-7fa6-4b5a-83ef-a5240cfe863e">000-20859</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_6d2ff604-a835-4b72-995c-373d6274e622">75-2287752</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_76f1a2b9-4a66-4549-a925-037685cb200a">919 E. HILLSDALE BLVD</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_922a7db1-52bc-4c06-9a78-6ba3e10931ab">SUITE 250</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_b6a0b199-c016-46a1-b22f-01bc4169235f">FOSTER CITY</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_ddce41ab-a1e2-4e05-b418-2303407a12c8">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_4147050f-c452-48a7-bb44-080cf1b2182e">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_1071b0fc-0926-4b97-9770-a12db4e63b77">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_e5402aa5-0a18-46db-ab9d-d1120e3bbbed">473-7700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_1fe41f89-4ac8-4533-9120-638c5f55563e">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_39e4bbfb-c130-4494-a3ed-7925a47e3b79">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_430d6f02-adf2-445b-8fca-ef3f03c9275d">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_ea547a96-6e73-41e3-8049-4fe2dc64de40">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_f7c32337-52b1-455c-90cb-d13597beeb97">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_039b3c9d-d9ad-4548-a5f9-5283c0dda4e4">GERN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_84400f07-cee6-46da-bd29-0d4d6ef86be7">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_fd658c12-c345-4597-b50d-ad46331f0ffe"
      id="F_fe33a804-9aa1-41a3-937e-23fa499276ff">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
